{"id":29595,"date":"2025-05-04T14:35:34","date_gmt":"2025-05-04T12:35:34","guid":{"rendered":"https:\/\/semaxpolska.com\/?page_id=29595"},"modified":"2026-09-04T11:49:21","modified_gmt":"2026-09-04T09:49:21","slug":"dopamin-a-jeho-vliv-na-nas-kazdodenni-zivot","status":"publish","type":"post","link":"https:\/\/bioevidencehub.com\/cs\/dopamina-i-jej-wplyw-na-nasze-codzienne-zycie\/","title":{"rendered":"Dopamin a jeho vliv na n\u00e1\u0161 ka\u017edodenn\u00ed \u017eivot"},"content":{"rendered":"<h2>Obsah<\/h2>\n<ol>\n<li><a href=\"#_Toc195560237\">Co je to dopamin? 1<\/a><\/li>\n<li><a href=\"#_Toc195560238\">Dopamin jako neurotransmiter a hormon. 1<\/a><\/li>\n<li><a href=\"#_Toc195560239\">Chemick\u00e1 podstata dopaminu. 2<\/a><\/li>\n<li><a href=\"#_Toc195560240\">Fyziologick\u00e9 a biologick\u00e9 vlastnosti. 2<\/a><\/li>\n<li><a href=\"#_Toc195560241\">Mechanismus \u00fa\u010dinku. 2<\/a><\/li>\n<li><a href=\"#_Toc195560242\">Dopaminov\u00e9 receptory. 2<\/a><\/li>\n<li><a href=\"#_Toc195560243\">Dopamin v centr\u00e1ln\u00ed nervov\u00e9 soustav\u011b.... 3<\/a><\/li>\n<li><a href=\"#_Toc195560244\">Dopamin v perifern\u00edm syst\u00e9mu.... 3<\/a><\/li>\n<li><a href=\"#_Toc195560245\">Dopamin a jeho vliv na dal\u0161\u00ed neurotransmitery 4<\/a><\/li>\n<li><a href=\"#_Toc195560246\">Kombinace dopaminu a serotoninu: 4<\/a><\/li>\n<li><a href=\"#_Toc195560247\">Kombinace dopaminu a noradrenalinu: 4<\/a><\/li>\n<li><a href=\"#_Toc195560248\">Kombinace dopaminu a glutam\u00e1tu: 4<\/a><\/li>\n<li><a href=\"#_Toc195560249\">Kombinace dopaminu a GABA: 5<\/a><\/li>\n<li><a href=\"#_Toc195560250\">Dopamin a kortizol 5<\/a><\/li>\n<li><a href=\"#_Toc195560251\">Dopamin a oxytocin. 5<\/a><\/li>\n<li><a href=\"#_Toc195560252\">Dopamin a endorfiny. 5<\/a><\/li>\n<li><a href=\"#_Toc195560253\">Dopamin a acetylcholin. 6<\/a><\/li>\n<li><a href=\"#_Toc195560254\">V\u00fdkyvy n\u00e1lady s hladinou dopaminu. 6<\/a><\/li>\n<li><a href=\"#_Toc195560255\">Dopamin a syst\u00e9m odm\u011bn. 6<\/a><\/li>\n<li><a href=\"#_Toc195560256\">Dopamin a okruh zvy\u0161uj\u00edc\u00ed pot\u011b\u0161en\u00ed. 6<\/a><\/li>\n<li><a href=\"#_Toc195560257\">Dopamin a reakce na stres. 7<\/a><\/li>\n<li><a href=\"#_Toc195560258\">Dopamin a motiva\u010dn\u00ed syst\u00e9m 7<\/a><\/li>\n<li><a href=\"#_Toc195560259\">Dopamin a \"h\u00e9donistick\u00fd b\u011b\u017e\u00edc\u00ed p\u00e1s\". 7<\/a><\/li>\n<li><a href=\"#_Toc195560260\">Dopamin a sp\u00e1nek. 7<\/a><\/li>\n<li><a href=\"#_Toc195560261\">Stimulace dopaminov\u00fdch receptor\u016f k modulaci dopaminergn\u00edch \u00fa\u010dink\u016f. 8<\/a><\/li>\n<li><a href=\"#_Toc195560262\">Dopaminergn\u00ed reakce a \u00fa\u010dinky. 8<\/a><\/li>\n<li><a href=\"#_Toc195560263\">Vn\u011bj\u0161\u00ed faktory stimuluj\u00edc\u00ed dopaminov\u00e9 receptory. 8<\/a><\/li>\n<li><a href=\"#_Toc195560264\">Vnit\u0159n\u00ed faktory stimuluj\u00edc\u00ed dopaminov\u00e9 receptory. 9<\/a><\/li>\n<li><a href=\"#_Toc195560265\">Synergick\u00e9 \u00fa\u010dinky a kombinovan\u00e9 podn\u011bty. 9<\/a><\/li>\n<li><a href=\"#_Toc195560266\">Inhibice zp\u011btn\u00e9ho vychyt\u00e1v\u00e1n\u00ed dopaminu. 10<\/a><\/li>\n<li><a href=\"#_Toc195560267\">Mechanismus inhibice zp\u011btn\u00e9ho vychyt\u00e1v\u00e1n\u00ed dopaminu. 10<\/a><\/li>\n<li><a href=\"#_Toc195560268\">L\u00e1tky, kter\u00e9 inhibuj\u00ed zp\u011btn\u00e9 vychyt\u00e1v\u00e1n\u00ed dopaminu. 10<\/a><\/li>\n<li><a href=\"#_Toc195560269\">\u00da\u010dinky inhibice zp\u011btn\u00e9ho vychyt\u00e1v\u00e1n\u00ed dopaminu. 11<\/a><\/li>\n<li><a href=\"#_Toc195560270\">Dopl\u0148ky ke zv\u00fd\u0161en\u00ed hladiny dopaminu. 11<\/a><\/li>\n<li><a href=\"#_Toc195560271\">Vliv bromantanu na hladinu dopaminu. 12<\/a><\/li>\n<li><a href=\"#_Toc195560272\">Vliv aniracetamu na hladinu dopaminu. 13<\/a><\/li>\n<li><a href=\"#_Toc195560273\">Vliv teakrinu na hladinu dopaminu. 13<\/a><\/li>\n<li><a href=\"#_Toc195560274\">Vliv mucuny na hladinu dopaminu. 14<\/a><\/li>\n<li><a href=\"#_Toc195560275\">Testov\u00e1n\u00ed hladiny dopaminu - stimulace dopaminergn\u00edch \u00fa\u010dink\u016f na vlastn\u00ed k\u016f\u017ei! 15<\/a><\/li>\n<li><a href=\"#_Toc195560276\">Mozkov\u00e9 hacky pro zv\u00fd\u0161en\u00ed hladiny dopaminu - z pohledu neurov\u011bdce.... 16<\/a><\/li>\n<li><a href=\"#_Toc195560277\">Konzumace obl\u00edben\u00fdch j\u00eddel (nebo sladkost\u00ed) 16<\/a><\/li>\n<li><a href=\"#_Toc195560278\">Od\u010derp\u00e1v\u00e1n\u00ed dopaminu ze soci\u00e1ln\u00edch m\u00e9di\u00ed. 16<\/a><\/li>\n<li><a href=\"#_Toc195560279\">Studen\u00e9 sprchy. 16<\/a><\/li>\n<li><a href=\"#_Toc195560280\">Vystaven\u00ed slune\u010dn\u00edmu z\u00e1\u0159en\u00ed. 16<\/a><\/li>\n<li><a href=\"#_Toc195560281\">Odkazy: 16<\/a><\/li>\n<\/ol>\n<h2>Co je to dopamin?<\/h2>\n<p>Dopamin je chemick\u00e1 l\u00e1tka, kter\u00e1 p\u016fsob\u00ed jako neurotransmiter a hormon. Hraje d\u016fle\u017eitou roli v n\u011bkolika d\u016fle\u017eit\u00fdch t\u011blesn\u00fdch procesech, v\u010detn\u011b pohybu, motivace, pot\u011b\u0161en\u00ed a odm\u011bny. Dopamin je sou\u010d\u00e1st\u00ed skupiny katecholamin\u016f, do kter\u00e9 pat\u0159\u00ed i dal\u0161\u00ed kl\u00ed\u010dov\u00e9 chemick\u00e9 l\u00e1tky, jako je noradrenalin (norepinefrin) a adrenalin (epinefrin). Tyto l\u00e1tky maj\u00ed z\u00e1sadn\u00ed v\u00fdznam pro regulaci r\u016fzn\u00fdch aspekt\u016f t\u011bla a mozku, od n\u00e1lady a\u017e po \u0159\u00edzen\u00ed motoriky. <a href=\"https:\/\/www.nature.com\/articles\/s41593-018-0152-y\" target=\"_blank\" rel=\"noopener\"><sup>(1)<\/sup><\/a><\/p>\n<h3>Dopamin jako neurotransmiter a hormon<\/h3>\n<h4>1. jako neurotransmiter:<\/h4>\n<p>Neurotransmiter je molekula, kter\u00e1 p\u0159en\u00e1\u0161\u00ed sign\u00e1ly mezi nervov\u00fdmi bu\u0148kami (neurony) prost\u0159ednictv\u00edm synaps\u00ed (mezer mezi neurony). Dopamin je produkov\u00e1n v mozku a uvol\u0148ov\u00e1n z neuron\u016f, kde pak komunikuje s dal\u0161\u00edmi neurony a pom\u00e1h\u00e1 regulovat \u0159adu funkc\u00ed, od pohybu po zpracov\u00e1n\u00ed emoc\u00ed. V mozku je dopamin produkov\u00e1n p\u0159edev\u0161\u00edm v oblastech, jako je \u010dern\u00e1 hmota a ventr\u00e1ln\u00ed tegment\u00e1ln\u00ed oblast (VTA), co\u017e jsou oblasti spojen\u00e9 se zpracov\u00e1n\u00edm odm\u011bny a \u0159\u00edzen\u00edm motoriky. <a href=\"https:\/\/books.google.com.pk\/books?hl=en&amp;lr=&amp;id=e4kLiI_kSGUC&amp;oi=fnd&amp;pg=PP1&amp;dq=dopamine+as+neurotransmitter&amp;ots=pDruwGaE5j&amp;sig=wGlK1uOpvpmB0c7ulnNIXApSyVg&amp;redir_esc=y#v=onepage&amp;q=dopamine%20as%20neurotransmitter&amp;f=false\" target=\"_blank\" rel=\"noopener\"><sup>(2)<\/sup><\/a><\/p>\n<h4>2. jako hormon:<\/h4>\n<p>Dopamin p\u016fsob\u00ed tak\u00e9 jako hormon, kdy\u017e je uvol\u0148ov\u00e1n do krevn\u00edho ob\u011bhu ur\u010dit\u00fdmi \u017el\u00e1zami, nap\u0159\u00edklad hypotalamem. Pod\u00edl\u00ed se na regulaci r\u016fzn\u00fdch t\u011blesn\u00fdch funkc\u00ed, v\u010detn\u011b \u0159\u00edzen\u00ed jin\u00fdch hormon\u016f. D\u016fle\u017eitou hormon\u00e1ln\u00ed funkc\u00ed dopaminu je inhibice prolaktinu, hormonu zodpov\u011bdn\u00e9ho za tvorbu ml\u00e9ka. Dopamin tedy hraje d\u016fle\u017eitou roli v regulaci reproduk\u010dn\u00edch funkc\u00ed, jako je laktace. <a href=\"https:\/\/academic.oup.com\/edrv\/article-abstract\/6\/4\/564\/2548821\" target=\"_blank\" rel=\"noopener\"><sup>(3)<\/sup><\/a><\/p>\n<h3>Chemick\u00e1 podstata dopaminu<\/h3>\n<h4>Chemick\u00fd vzorec: C\u2088H\u2081\u2081NO\u2082<\/h4>\n<p>Dopamin pat\u0159\u00ed do skupiny katecholamin\u016f, kter\u00e9 se vyzna\u010duj\u00ed benzenov\u00fdm kruhem se dv\u011bma hydroxylov\u00fdmi skupinami a aminovou skupinou (-NH\u2082). Dopamin se vyr\u00e1b\u00ed z aminokyseliny tyrosinu, kter\u00e1 se s\u00e9ri\u00ed enzymatick\u00fdch reakc\u00ed nejprve p\u0159em\u011b\u0148uje na L-DOPA a pot\u00e9 na dopamin. Na tomto procesu se pod\u00edlej\u00ed enzymy tyrosinhydroxyl\u00e1za a dekarboxyl\u00e1za aromatick\u00fdch L-aminokyselin. <a href=\"https:\/\/pubs.acs.org\/doi\/full\/10.1021\/la204831b?casa_token=Ty8VXX1bQj8AAAAA%3AktuRZiEL9F6yyQ4wAu_goi-M2D5L_P8V3XszBA5FyRJcXruCnfCl3xKhUtKCkluM1itLoaFh5nobb6b0\" target=\"_blank\" rel=\"noopener\"><sup>(4)<\/sup><\/a><\/p>\n<h3>Fyziologick\u00e9 a biologick\u00e9 vlastnosti<\/h3>\n<h4>Neurofyziologick\u00e9 funkce:<\/h4>\n<p>Dopamin hraje d\u016fle\u017eitou roli v regulaci pohybu. Nedostate\u010dn\u00e1 hladina dopaminu v oblastech, jako jsou baz\u00e1ln\u00ed ganglia mozku, je spojov\u00e1na s Parkinsonovou chorobou, kter\u00e1 zp\u016fsobuje t\u0159es, ztuhlost a zpomalen\u00e9 pohyby. Dopamin je nezbytn\u00fd pro syst\u00e9m odm\u011b\u0148ov\u00e1n\u00ed v mozku. Uvol\u0148uje se v reakci na p\u0159\u00edjemn\u00e9 podn\u011bty, jako je j\u00eddlo nebo soci\u00e1ln\u00ed interakce, a posiluje ur\u010dit\u00e9 chov\u00e1n\u00ed t\u00edm, \u017ee vyvol\u00e1v\u00e1 pocit uspokojen\u00ed nebo pot\u011b\u0161en\u00ed. Dopamin se pod\u00edl\u00ed na u\u010den\u00ed, pam\u011bti a rozhodov\u00e1n\u00ed, zejm\u00e9na v souvislosti s odm\u011bnami. Pom\u00e1h\u00e1 p\u0159i motiva\u010dn\u00edch aktivit\u00e1ch a u\u010den\u00ed prost\u0159ednictv\u00edm posilov\u00e1n\u00ed. Dopamin ovliv\u0148uje tak\u00e9 regulaci n\u00e1lady a poruchy dopaminov\u00e9 signalizace jsou spojov\u00e1ny s depresemi a bipol\u00e1rn\u00ed afektivn\u00ed poruchou, kter\u00e9 mohou b\u00fdt d\u016fsledkem nerovnov\u00e1hy v dopaminov\u00fdch syst\u00e9mech. <a href=\"\/cs\/Krzymowski,%20T.,%20&amp;%20Stefanczyk-Krzymowska,%20S.%20(2015).%20New%20facts%20and%20the%20concept%20of%20physiological%20regulation%20of%20the%20dopaminergic%20system%20function%20and%20its%20disorders.%20J%20Physiol%20Pharmacol,%2066(3),%20331-341.\/\"><sup>(5)<\/sup><\/a><\/p>\n<h4>Dal\u0161\u00ed biologick\u00e9 role:<\/h4>\n<p>Dopamin ovliv\u0148uje tak\u00e9 kardiovaskul\u00e1rn\u00ed syst\u00e9m, kde m\u016f\u017ee prost\u0159ednictv\u00edm interakc\u00ed s receptory v t\u011ble ovliv\u0148ovat srde\u010dn\u00ed frekvenci a krevn\u00ed tlak. Toto p\u016fsoben\u00ed je v\u0161ak druhotn\u00e9 vzhledem k jeho \u00faloze v mozku. <a href=\"https:\/\/www.mdpi.com\/1422-0067\/24\/5\/5042\" target=\"_blank\" rel=\"noopener\"><sup>(6<\/sup><\/a>) Hraje roli v tr\u00e1vic\u00edm syst\u00e9mu, ovliv\u0148uje motilitu a regulaci chuti k j\u00eddlu a m\u00e1 vliv na reflexy ve st\u0159evech. <a href=\"https:\/\/link.springer.com\/article\/10.1007\/s001340051279\" target=\"_blank\" rel=\"noopener\"><sup>(7)<\/sup><\/a><\/p>\n<p>&nbsp;<\/p>\n<h3>Mechanismus \u00fa\u010dinku<\/h3>\n<p>Mechanismus \u00fa\u010dinku dopaminu zahrnuje jeho funkci jako neurotransmiteru v mozku i jako hormonu v perifern\u00edm syst\u00e9mu. Sv\u00e9 \u00fa\u010dinky uplat\u0148uje p\u0159edev\u0161\u00edm vazbou na dopaminov\u00e9 receptory, kter\u00e9 se nach\u00e1zej\u00ed v centr\u00e1ln\u00edm nervov\u00e9m syst\u00e9mu (CNS) a r\u016fzn\u00fdch perifern\u00edch tk\u00e1n\u00edch. Tyto receptory jsou sou\u010d\u00e1st\u00ed v\u011bt\u0161\u00ed rodiny receptor\u016f sp\u0159a\u017een\u00fdch s G proteinem (GPCR), kter\u00e9 po aktivaci dopaminem zprost\u0159edkov\u00e1vaj\u00ed intracelul\u00e1rn\u00ed sign\u00e1ln\u00ed dr\u00e1hy. <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0959438818302587?casa_token=HsC5mNyRRrgAAAAA:vETxwdrB3Cw9AmPPm-4OlLxAXcnNHvbdhRkOuvwGJyvZvrMCGR5e66MGWnkc16JV9SsbAlc_vaI\" target=\"_blank\" rel=\"noopener\"><sup>(8)<\/sup><\/a><\/p>\n<h3>Dopaminov\u00e9 receptory<\/h3>\n<p>Dopamin p\u016fsob\u00ed na p\u011bt r\u016fzn\u00fdch podtyp\u016f receptor\u016f D1, D2, D3, D4 a D5. Tyto receptory lze obecn\u011b rozd\u011blit do dvou skupin na z\u00e1klad\u011b jejich bun\u011b\u010dn\u00e9ho p\u016fsoben\u00ed:<\/p>\n<ol>\n<li>\n<h4>receptory podobn\u00e9 D1 (D1 a D5):<\/h4>\n<p>Tyto receptory jsou p\u0159ev\u00e1\u017en\u011b excita\u010dn\u00ed. Kdy\u017e se dopamin nav\u00e1\u017ee na receptory typu D1, aktivuje enzym adenylylcykl\u00e1zu, kter\u00fd zvy\u0161uje hladinu cyklick\u00e9ho AMP (cAMP) v bu\u0148ce. Toto zv\u00fd\u0161en\u00ed cAMP aktivuje proteinkin\u00e1zu A (PKA), kter\u00e1 n\u00e1sledn\u011b moduluje r\u016fzn\u00e9 bun\u011b\u010dn\u00e9 procesy, jako je neuron\u00e1ln\u00ed excitabilita, synaptick\u00e1 plasticita a genov\u00e1 exprese. V mozku se tyto receptory pod\u00edlej\u00ed na procesech, jako je u\u010den\u00ed, pam\u011b\u0165 a regulace n\u00e1lady. <a href=\"\/cs\/Beaulieu,%20J.%20M.,%20Espinoza,%20S.,%20&amp;%20Gainetdinov,%20R.%20R.%20(2015).%20Dopamine%20receptors\u2013IUPHAR%20R%20eview%2013.%20British%20journal%20of%20pharmacology,%20172(1),%201-23.\/\"><sup>(9)<\/sup><\/a><\/li>\n<li>\n<h4><strong>receptory podobn\u00e9 D2 (D2, D3, D4):<\/strong><\/h4>\n<p>Tyto receptory maj\u00ed obecn\u011b inhibi\u010dn\u00ed \u00fa\u010dinek. Vazba dopaminu na receptory podobn\u00e9 D2 inhibuje aktivitu adenylylcykl\u00e1zy, co\u017e vede ke sn\u00ed\u017een\u00ed hladiny cAMP. Tento pokles cAMP sni\u017euje aktivitu PKA, co\u017e ovliv\u0148uje funkci iontov\u00fdch kan\u00e1l\u016f a excitabilitu bun\u011bk. Receptory podobn\u00e9 D2 jsou zvl\u00e1\u0161t\u011b d\u016fle\u017eit\u00e9 p\u0159i regulaci motorick\u00e9 kontroly, odm\u011bny a kognitivn\u00edch funkc\u00ed. Dysfunkce signalizace D2 receptor\u016f je spojena s poruchami, jako je Parkinsonova choroba a schizofrenie. <a href=\"\/cs\/Beaulieu,%20J.%20M.,%20Espinoza,%20S.,%20&amp;%20Gainetdinov,%20R.%20R.%20(2015).%20Dopamine%20receptors\u2013IUPHAR%20R%20eview%2013.%20British%20journal%20of%20pharmacology,%20172(1),%201-23.\/\"><sup>(9)<\/sup><\/a><\/li>\n<\/ol>\n<h3>Dopamin v centr\u00e1ln\u00ed nervov\u00e9 soustav\u011b<\/h3>\n<p>Dopamin m\u00e1 v\u00fdznamn\u00e9 \u00fa\u010dinky na n\u011bkolik kritick\u00fdch drah v mozku. Mezi tyto dr\u00e1hy pat\u0159\u00ed mezolimbick\u00e1, mezokortik\u00e1ln\u00ed a nigrostriat\u00e1ln\u00ed dr\u00e1ha, z nich\u017e ka\u017ed\u00e1 p\u0159isp\u00edv\u00e1 k r\u016fzn\u00fdm aspekt\u016fm chov\u00e1n\u00ed a funkce.<\/p>\n<ul>\n<li>\n<h4>Mezolimbick\u00e1 cesta:<\/h4>\n<p>Dopamin uvol\u0148ovan\u00fd v t\u00e9to dr\u00e1ze hraje kl\u00ed\u010dovou roli v syst\u00e9mu odm\u011bny. Pod\u00edl\u00ed se na posilov\u00e1n\u00ed chov\u00e1n\u00ed t\u00edm, \u017ee poskytuje pocity pot\u011b\u0161en\u00ed nebo uspokojen\u00ed, zejm\u00e9na v reakci na odm\u011b\u0148uj\u00edc\u00ed podn\u011bty, jako je j\u00eddlo, sex nebo soci\u00e1ln\u00ed interakce. Tato dr\u00e1ha je spojov\u00e1na se z\u00e1vislost\u00ed, proto\u017ee drogy mohou p\u0159evz\u00edt signalizaci dopaminu, co\u017e vede k pos\u00edlen\u00ed chov\u00e1n\u00ed, kter\u00e9 vede k vyhled\u00e1v\u00e1n\u00ed drog. <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0149763406001102?casa_token=wNW7P2AVPG4AAAAA:EFGU-aDDUBLDT1uTuGzTM-9E3bhr7qqqf31ocW3L8cBPUjO4aSZ4IVFz5JdArfYGl-KOyvKaWh4\" target=\"_blank\" rel=\"noopener\"><sup>(10)<\/sup><\/a><\/li>\n<li>\n<h4>Nigrostriat\u00e1ln\u00ed cesta:<\/h4>\n<p>Dopamin v t\u00e9to dr\u00e1ze je nezbytn\u00fd pro \u0159\u00edzen\u00ed motoriky. Tvo\u0159\u00ed se v \u010dern\u00e9 hmot\u011b a je p\u0159en\u00e1\u0161en do striata. Dopamin pom\u00e1h\u00e1 modulovat motorick\u00e9 obvody pod\u00edlej\u00edc\u00ed se na jemn\u00fdch motorick\u00fdch pohybech a koordinaci. Ztr\u00e1ta neuron\u016f produkuj\u00edc\u00edch dopamin v t\u00e9to dr\u00e1ze vede k Parkinsonov\u011b chorob\u011b, p\u0159i n\u00ed\u017e se objevuj\u00ed motorick\u00e9 p\u0159\u00edznaky, jako je t\u0159es, rigidita a bradykineze (zpomalen\u00ed pohybu). <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0149763406001102?casa_token=wNW7P2AVPG4AAAAA:EFGU-aDDUBLDT1uTuGzTM-9E3bhr7qqqf31ocW3L8cBPUjO4aSZ4IVFz5JdArfYGl-KOyvKaWh4\" target=\"_blank\" rel=\"noopener\"><sup>(10)<\/sup><\/a><\/li>\n<li>\n<h4><strong>Mezokortik\u00e1ln\u00ed dr\u00e1ha: <\/strong><\/h4>\n<p>Dopamin v mezokortik\u00e1ln\u00ed dr\u00e1ze ovliv\u0148uje kognitivn\u00ed funkce, emo\u010dn\u00ed regulaci a exekutivn\u00ed funkce. Pod\u00edl\u00ed se na procesech, jako je rozhodov\u00e1n\u00ed, pozornost a regulace n\u00e1lady. Dysfunkce t\u00e9to dr\u00e1hy je spojov\u00e1na se schizofreni\u00ed a dal\u0161\u00edmi poruchami n\u00e1lady, p\u0159i nich\u017e je naru\u0161ena kognitivn\u00ed a emo\u010dn\u00ed regulace. <a href=\"https:\/\/europepmc.org\/article\/med\/17886476\" target=\"_blank\" rel=\"noopener\"><sup>(11)<\/sup><\/a><\/li>\n<\/ul>\n<h3>Dopamin v perifern\u00edm syst\u00e9mu<\/h3>\n<p>Krom\u011b centr\u00e1ln\u00edho p\u016fsoben\u00ed hraje dopamin v t\u011ble tak\u00e9 hormon\u00e1ln\u00ed roli. V perifern\u00edm syst\u00e9mu p\u016fsob\u00ed dopamin p\u0159edev\u0161\u00edm jako vazodilat\u00e1tor. M\u00e1 vliv na uvoln\u011bn\u00ed hladk\u00e9ho svalstva v c\u00e9v\u00e1ch, co\u017e vede ke sn\u00ed\u017een\u00ed krevn\u00edho tlaku. Tento \u00fa\u010dinek je zvl\u00e1\u0161t\u011b d\u016fle\u017eit\u00fd pro funkci ledvin, kde dopamin pom\u00e1h\u00e1 regulovat pr\u016ftok krve ledvinami, vylu\u010dov\u00e1n\u00ed sod\u00edku a celkovou funkci ledvin. \u00daloha dopaminu v kardiovaskul\u00e1rn\u00edm syst\u00e9mu je slo\u017eit\u011bj\u0161\u00ed, proto\u017ee jeho \u00fa\u010dinky se mohou li\u0161it v z\u00e1vislosti na koncentraci a konkr\u00e9tn\u00edm typu dopaminov\u00e9ho receptoru. <a href=\"https:\/\/www.researchgate.net\/profile\/Seyed-Khosrow-Tayebati\/publication\/11031049_The_peripheral_dopaminergic_system_morphological_analysis_functional_and_clinical_applications\/links\/55edc0cb08aedecb68fbaf1f\/The-peripheral-dopaminergic-system-morphological-analysis-functional-and-clinical-applications.pdf\" target=\"_blank\" rel=\"noopener\"><sup>(12)<\/sup><\/a><\/p>\n<p>&nbsp;<\/p>\n<h3>Dopamin a jeho vliv na dal\u0161\u00ed neurotransmitery<\/h3>\n<p>Dopamin, a\u010dkoli m\u00e1 z\u00e1sadn\u00ed v\u00fdznam pro fungov\u00e1n\u00ed mozku, nen\u00ed jedin\u00fdm neurotransmiterem, kter\u00fd se pod\u00edl\u00ed na regulaci n\u00e1lady. Spolupracuje s n\u011bkolika dal\u0161\u00edmi neurotransmitery, jako je serotonin, noradrenalin, glutam\u00e1t a GABA, a m\u00e1 komplexn\u00ed \u00fa\u010dinky na n\u00e1ladu, chov\u00e1n\u00ed a kognitivn\u00ed funkce. Ka\u017ed\u00fd z t\u011bchto neurotransmiter\u016f m\u00e1 svou vlastn\u00ed roli, ale jejich vz\u00e1jemn\u00e9 p\u016fsoben\u00ed, zejm\u00e9na v ur\u010dit\u00fdch kombinac\u00edch, m\u016f\u017ee v\u00fdznamn\u011b ovlivnit to, jak se c\u00edt\u00edme a chov\u00e1me.<\/p>\n<p>Zp\u016fsob interakce dopaminu s ostatn\u00edmi neurotransmitery m\u00e1 p\u0159\u00edm\u00fd vliv na n\u00e1ladu, emo\u010dn\u00ed stav a chov\u00e1n\u00ed. Zde je n\u011bkolik p\u0159\u00edklad\u016f, jak dopamin a jeho kombinace ovliv\u0148uj\u00ed n\u00e1ladu:<\/p>\n<h3>Kombinace dopaminu a serotoninu:<\/h3>\n<h4>Vyv\u00e1\u017een\u00fd dopamin a serotonin:<\/h4>\n<p>Kdy\u017e jsou dopamin a serotonin v harmonii, podporuj\u00ed pozitivn\u00ed n\u00e1ladu, zv\u00fd\u0161enou motivaci a emo\u010dn\u00ed pohodu. Tato rovnov\u00e1ha m\u016f\u017ee zv\u00fd\u0161it pocity pot\u011b\u0161en\u00ed, ani\u017e by vedla k nadm\u011brn\u00e9mu vzru\u0161en\u00ed nebo \u00fazkosti.<\/p>\n<h4>Nedostatek dopaminu s vysokou hladinou serotoninu:<\/h4>\n<p>N\u00edzk\u00e1 hladina dopaminu v kombinaci s vysokou hladinou serotoninu m\u016f\u017ee v\u00e9st k emo\u010dn\u00ed stabilit\u011b, ale k nedostatku motivace a n\u00edzk\u00e9 hladin\u011b energie. To m\u016f\u017ee p\u0159isp\u00edvat ke stavu spokojenosti, ale nedostatku motivace nebo lhostejnosti. <a href=\"https:\/\/www.pnas.org\/doi\/abs\/10.1073\/pnas.1201547109\" target=\"_blank\" rel=\"noopener\"><sup>(13)<\/sup><\/a><\/p>\n<h3>Kombinace dopaminu a noradrenalinu:<\/h3>\n<h4>Zv\u00fd\u0161en\u00ed hladiny dopaminu a norepinefrinu:<\/h4>\n<p>Kdy\u017e jsou oba neurotransmitery zv\u00fd\u0161en\u00e9, \u010dlov\u011bk se m\u016f\u017ee c\u00edtit vysoce motivovan\u00fd, energick\u00fd a soust\u0159ed\u011bn\u00fd, se zv\u00fd\u0161enou \u00farovn\u00ed motivace a pozornosti. Tato kombinace se \u010dasto projevuje zv\u00fd\u0161enou produktivitou a soust\u0159ed\u011bnost\u00ed.<\/p>\n<h4>Nadbytek dopaminu v kombinaci s noradrenalinem:<\/h4>\n<p>Nadbytek dopaminu v kombinaci s p\u0159\u00edli\u0161 velk\u00fdm mno\u017estv\u00edm noradrenalinu m\u016f\u017ee v\u00e9st ke zv\u00fd\u0161en\u00e9 \u00fazkosti, impulzivit\u011b nebo manick\u00e9mu chov\u00e1n\u00ed, proto\u017ee mozek p\u0159ech\u00e1z\u00ed do hyperaktivn\u00edho a pohotovostn\u00edho re\u017eimu. <a href=\"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/fullarticle\/481645\" target=\"_blank\" rel=\"noopener\"><sup>(14)<\/sup><\/a><\/p>\n<h3>Kombinace dopaminu a glutam\u00e1tu:<\/h3>\n<h4>Synchronizace dopaminu a glutam\u00e1tu:<\/h4>\n<p>Tyto neurotransmitery spole\u010dn\u011b podporuj\u00ed pam\u011b\u0165 a u\u010den\u00ed a udr\u017euj\u00ed motivaci. Zdrav\u00e1 rovnov\u00e1ha podporuje efektivn\u00ed u\u010den\u00ed a produktivn\u00ed chov\u00e1n\u00ed, proto\u017ee dopamin zvy\u0161uje motivaci a glutam\u00e1t umo\u017e\u0148uje kognitivn\u00ed procesy.<\/p>\n<h4>Nedostatek dopaminu s dysfunkc\u00ed glutam\u00e1tu<strong>:<\/strong><\/h4>\n<p>V p\u0159\u00edpadech, kdy je hladina dopaminu n\u00edzk\u00e1 a glutam\u00e1t je deregulovan\u00fd, m\u016f\u017ee doch\u00e1zet k poruch\u00e1m kognitivn\u00edch funkc\u00ed, probl\u00e9m\u016fm s pam\u011bt\u00ed nebo soust\u0159ed\u011bn\u00edm. To m\u016f\u017ee p\u0159isp\u00edvat k p\u0159\u00edznak\u016fm poruchy pozornosti a dokonce i deprese. <a href=\"https:\/\/www.thieme-connect.com\/products\/ejournals\/html\/10.1055\/s-0031-1273707\" target=\"_blank\" rel=\"noopener\"><sup>(15)<\/sup><\/a><\/p>\n<h3>Kombinace dopaminu a GABA:<\/h3>\n<h4>GABA-regulovan\u00fd dopamin:<\/h4>\n<p>Dopamin a GABA mus\u00ed pracovat v tandemu, aby podpo\u0159ily rovnov\u00e1hu akce a relaxace. Jejich zdrav\u00e1 kombinace vytv\u00e1\u0159\u00ed stabiln\u00ed emo\u010dn\u00ed stav, v n\u011bm\u017e jsou jedinci motivovan\u00ed, ale nejsou zahlceni \u00fazkost\u00ed nebo hyperaktivitou.<\/p>\n<h3>Vysok\u00e9 hladiny dopaminu a n\u00edzk\u00e9 hladiny GABA:<\/h3>\n<p>Tato nerovnov\u00e1ha m\u016f\u017ee v\u00e9st k impulzivn\u00edmu chov\u00e1n\u00ed, podr\u00e1\u017ed\u011bnosti, \u00fazkosti a nadm\u011brn\u00e9 stimulaci. Naopak nedostatek dopaminu v kombinaci s vysokou hladinou GABA m\u016f\u017ee v\u00e9st k ploch\u00e9, n\u00edzkoenergetick\u00e9 n\u00e1lad\u011b, \u010dasto spojen\u00e9 s depres\u00ed. <a href=\"https:\/\/psycnet.apa.org\/fulltext\/2014-56250-020.html?source=post_page---------------------------\" target=\"_blank\" rel=\"noopener\"><sup>(16)<\/sup><\/a><\/p>\n<h3>Dopamin a kortizol<\/h3>\n<p>Kortizol je hlavn\u00ed stresov\u00fd hormon, kter\u00fd se uvol\u0148uje z nadledvinek v reakci na stres. Dopamin a kortizol na sebe slo\u017eit\u011b p\u016fsob\u00ed. Zat\u00edmco dopamin m\u016f\u017ee poh\u00e1n\u011bt motivaci a chov\u00e1n\u00ed zam\u011b\u0159en\u00e9 na hled\u00e1n\u00ed odm\u011bny, kortizol m\u016f\u017ee v podm\u00ednk\u00e1ch siln\u00e9ho stresu dopamin potla\u010dovat. Chronick\u00fd stres m\u016f\u017ee v\u00e9st ke sn\u00ed\u017een\u00ed citlivosti dopaminov\u00fdch receptor\u016f, co\u017e jedinc\u016fm zt\u011b\u017euje pro\u017e\u00edv\u00e1n\u00ed pot\u011b\u0161en\u00ed a motivace. Nap\u0159\u00edklad p\u0159i chronick\u00e9m stresu nebo \u00fazkosti m\u016f\u017ee souhra zv\u00fd\u0161en\u00e9 hladiny kortizolu a sn\u00ed\u017een\u00e9 funkce dopaminu p\u0159isp\u00edvat k pocitu vyho\u0159en\u00ed, nedostatku motivace a depresi. <a href=\"https:\/\/academic.oup.com\/ejendo\/article-abstract\/122\/1\/29\/6771151\" target=\"_blank\" rel=\"noopener\"><sup>(17)<\/sup><\/a><\/p>\n<h3>Dopamin a oxytocin<\/h3>\n<p>Oxytocin, zn\u00e1m\u00fd jako \"hormon vazby\", hraje kl\u00ed\u010dovou roli v soci\u00e1ln\u00ed vazb\u011b, d\u016fv\u011b\u0159e a regulaci emoc\u00ed. Dopamin a oxytocin mohou posilovat soci\u00e1ln\u00ed vazby a pocity l\u00e1sky a n\u00e1klonnosti. Dopamin zvy\u0161uje pot\u011b\u0161en\u00ed a odm\u011bnu ze soci\u00e1ln\u00edch interakc\u00ed, zat\u00edmco oxytocin podporuje vazby a empatii. Kombinace dopaminu (spojen\u00e9ho s pot\u011b\u0161en\u00edm a odm\u011bnou) a oxytocinu (spojen\u00e9ho s vazbou a d\u016fv\u011brou) m\u016f\u017ee pos\u00edlit citov\u00e9 vazby a pocity n\u00e1klonnosti. <a href=\"https:\/\/www.mdpi.com\/2227-9059\/12\/11\/2440\" target=\"_blank\" rel=\"noopener\"><sup>(18)<\/sup><\/a><\/p>\n<h3>Dopamin a endorfiny<\/h3>\n<p>Endorfiny jsou p\u0159irozen\u00e9 mozkov\u00e9 l\u00e9ky proti bolesti a jsou spojeny s pocity euforie a pohody, kter\u00e9 se \u010dasto uvol\u0148uj\u00ed po cvi\u010den\u00ed nebo v reakci na p\u0159\u00edjemn\u00e9 aktivity. Endorfiny a dopamin spolupracuj\u00ed v mozkov\u00e9m syst\u00e9mu odm\u011bny a pot\u011b\u0161en\u00ed. Dopamin se pod\u00edl\u00ed na o\u010dek\u00e1v\u00e1n\u00ed pot\u011b\u0161en\u00ed, zat\u00edmco endorfiny se uvol\u0148uj\u00ed, kdy\u017e pot\u011b\u0161en\u00ed za\u017eijeme. Spole\u010dn\u011b p\u0159isp\u00edvaj\u00ed k pocitu \u0161t\u011bst\u00ed a spokojenosti. Euforie vyvolan\u00e1 cvi\u010den\u00edm (\u010dasto ozna\u010dovan\u00e1 jako \"b\u011b\u017eeck\u00e9 opojen\u00ed\") je v\u00fdsledkem uvol\u0148ov\u00e1n\u00ed dopaminu i endorfin\u016f, co\u017e vede ke zv\u00fd\u0161en\u00ed motivace a pozitivn\u00edmu pos\u00edlen\u00ed aktivity. <a href=\"https:\/\/pdfs.semanticscholar.org\/4fb3\/a88ff070092e0e0f0e3a8cd00c26be527f2f.pdf\" target=\"_blank\" rel=\"noopener\"><sup>(19)<\/sup><\/a><\/p>\n<h3>Dopamin a acetylcholin<\/h3>\n<p>Acetylcholin m\u00e1 z\u00e1sadn\u00ed v\u00fdznam pro pam\u011b\u0165, u\u010den\u00ed a ovl\u00e1d\u00e1n\u00ed sval\u016f. Hraje velkou roli ve schopnosti mozku zpracov\u00e1vat nov\u00e9 informace a pozornost. Vz\u00e1jemn\u00e9 p\u016fsoben\u00ed dopaminu a acetylcholinu v mozku m\u016f\u017ee ovliv\u0148ovat kognitivn\u00ed funkce. Nap\u0159\u00edklad u Parkinsonovy choroby doch\u00e1z\u00ed k nedostatku dopaminu, co\u017e vede k motorick\u00fdm a kognitivn\u00edm probl\u00e9m\u016fm. C\u00edlem jedn\u00e9 z l\u00e9\u010debn\u00fdch metod Parkinsonovy choroby je vyrovnat hladinu dopaminu a acetylcholinu a zlep\u0161it tak motorick\u00e9 funkce. U stav\u016f, jako je Parkinsonova choroba, mohou l\u00e9ky, kter\u00e9 zvy\u0161uj\u00ed aktivitu acetylcholinu (nap\u0159. anticholinergika), pomoci vyrovnat nedostatek dopaminu a sn\u00ed\u017eit t\u0159es nebo ztuhlost. <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/0006899391903848\" target=\"_blank\" rel=\"noopener\"><sup>(20)<\/sup><\/a><\/p>\n<h2>V\u00fdkyvy n\u00e1lady s hladinou dopaminu<\/h2>\n<p>Zm\u011bny n\u00e1lad \u010dasto \u00fazce souvisej\u00ed se zm\u011bnami hladin neurotransmiter\u016f, jako je dopamin, kter\u00fd hraje kl\u00ed\u010dovou roli v regulaci emoc\u00ed, motivace a zpracov\u00e1n\u00ed odm\u011bn v mozku. Kdy\u017e je hladina dopaminu vyrovnan\u00e1, jedinci obvykle za\u017e\u00edvaj\u00ed stabiln\u00ed n\u00e1ladu, pocit motivace a schopnost pro\u017e\u00edvat pot\u011b\u0161en\u00ed. Kol\u00eds\u00e1n\u00ed hladin dopaminu v\u0161ak m\u016f\u017ee v\u00e9st k v\u00fdrazn\u00fdm zm\u011bn\u00e1m n\u00e1lady. Zde je souhrn v\u011bdeck\u00fdch informac\u00ed o vlivu hladin dopaminu na zm\u011bny n\u00e1lady:<\/p>\n<h3>Dopamin a syst\u00e9m odm\u011bn<\/h3>\n<p>Dopamin je kl\u00ed\u010dovou sou\u010d\u00e1st\u00ed mozkov\u00e9ho syst\u00e9mu odm\u011bny, kter\u00fd je zodpov\u011bdn\u00fd za zpracov\u00e1n\u00ed p\u0159\u00edjemn\u00fdch z\u00e1\u017eitk\u016f a posilov\u00e1n\u00ed odm\u011b\u0148uj\u00edc\u00edho chov\u00e1n\u00ed. Kdy\u017e se dopamin uvol\u0148uje, vyvol\u00e1v\u00e1 pocity pot\u011b\u0161en\u00ed a uspokojen\u00ed, kter\u00e9 \u010dasto n\u00e1sleduj\u00ed po \u010dinnostech, jako je j\u00eddlo, socializace nebo dosa\u017een\u00ed c\u00edl\u016f. N\u00edzk\u00e1 hladina dopaminu m\u016f\u017ee br\u00e1nit pocit\u016fm pot\u011b\u0161en\u00ed nebo motivace, co\u017e vede k pocit\u016fm apatie, anhedonie (neschopnosti poci\u0165ovat pot\u011b\u0161en\u00ed) a n\u00edzk\u00e9 hladiny energie. Na druhou stranu vysok\u00e1 hladina dopaminu m\u016f\u017ee v\u00e9st ke zv\u00fd\u0161en\u00e9mu pot\u011b\u0161en\u00ed a vzru\u0161en\u00ed, ale pokud se dopaminu uvol\u0148uje p\u0159\u00edli\u0161 rychle, m\u016f\u017ee zp\u016fsobit nadm\u011brnou stimulaci, co\u017e vede k \u00fazkosti, podr\u00e1\u017ed\u011bnosti a dokonce impulzivit\u011b. <a href=\"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1111\/j.1600-0447.2005.00540.x?casa_token=rG5BTN_AltwAAAAA%3A5VzH55lRpmqof2oMACNkGqtr4P_bTPywY8HzKUFtr_y0oArhUt5KY_LpBhxLosCp2bxaB9x51ZtNtTdu\" target=\"_blank\" rel=\"noopener\"><sup>(21)<\/sup><\/a><\/p>\n<h3>Dopamin a okruh zvy\u0161uj\u00edc\u00ed pot\u011b\u0161en\u00ed<\/h3>\n<p>Dopamin hraje kl\u00ed\u010dovou roli v mezolimbick\u00e9 dopaminergn\u00ed dr\u00e1ze, kter\u00e1 je \"centrem odm\u011bny\" v mozku. Tato dr\u00e1ha zahrnuje kl\u00ed\u010dov\u00e9 struktury, jako je nucleus accumbens, kter\u00fd pom\u00e1h\u00e1 regulovat pocity pot\u011b\u0161en\u00ed, a prefront\u00e1ln\u00ed k\u016fra, kter\u00e1 se pod\u00edl\u00ed na rozhodov\u00e1n\u00ed, pl\u00e1nov\u00e1n\u00ed a stanovov\u00e1n\u00ed c\u00edl\u016f. Kdy\u017e \u010dlov\u011bk za\u017eije n\u011bco p\u0159\u00edjemn\u00e9ho (nap\u0159. j\u00eddlo nebo kompliment), uvol\u0148uje se do t\u011bchto oblast\u00ed dopamin, kter\u00fd posiluje jeho chov\u00e1n\u00ed. Uvol\u0148ov\u00e1n\u00ed dopaminu pom\u00e1h\u00e1 upevnit asociaci mezi dan\u00fdm jedn\u00e1n\u00edm a pozitivn\u00edm z\u00e1\u017eitkem a motivuje jedince k tomu, aby v budoucnu vyhled\u00e1val podobn\u00e9 odm\u011bny. Pokud je hladina dopaminu v t\u00e9to dr\u00e1ze n\u00edzk\u00e1 nebo naru\u0161en\u00e1, syst\u00e9m posilov\u00e1n\u00ed odm\u011bny je naru\u0161en, co\u017e vede k obt\u00ed\u017e\u00edm s pro\u017e\u00edv\u00e1n\u00edm radosti nebo motivace. Naopak p\u0159\u00edli\u0161 vysok\u00e1 hladina dopaminu m\u016f\u017ee v\u00e9st k nadm\u011brn\u00e9mu vyhled\u00e1v\u00e1n\u00ed odm\u011bn, \u010dasto bez ohledu na n\u00e1sledky. <a href=\"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1111\/j.1600-0447.2005.00540.x?casa_token=rG5BTN_AltwAAAAA%3A5VzH55lRpmqof2oMACNkGqtr4P_bTPywY8HzKUFtr_y0oArhUt5KY_LpBhxLosCp2bxaB9x51ZtNtTdu\" target=\"_blank\" rel=\"noopener\"><sup>(21)<\/sup><\/a><\/p>\n<h3>Dopamin a reakce na stres<\/h3>\n<p>Chronick\u00fd stres m\u016f\u017ee v\u00fdznamn\u011b ovlivnit hladinu dopaminu, co\u017e vede ke zm\u011bn\u00e1m v regulaci n\u00e1lady. Vysok\u00e1 hladina kortizolu (stresov\u00e9ho hormonu) m\u016f\u017ee potla\u010dit schopnost dopaminu spr\u00e1vn\u011b fungovat. Chronick\u00fd stres nebo dlouhodob\u00e9 obdob\u00ed vysok\u00fdch hladin kortizolu m\u016f\u017ee znecitliv\u011bt dopaminov\u00e9 receptory, co\u017e mozku zt\u011b\u017euje reakci na sign\u00e1ly odm\u011bny. To m\u016f\u017ee v\u00e9st k nedostatku dopaminu, co\u017e p\u0159isp\u00edv\u00e1 k p\u0159\u00edznak\u016fm, jako je \u00fanava, smutek a nedostatek motivace. Naproti tomu akutn\u00ed stres nebo do\u010dasn\u00e9 zv\u00fd\u0161en\u00ed dopaminu (pozorovan\u00e9 ve chv\u00edl\u00edch zv\u00fd\u0161en\u00e9ho vzru\u0161en\u00ed nebo v\u00fdzvy) m\u016f\u017ee v\u00e9st k do\u010dasn\u00e9mu zv\u00fd\u0161en\u00ed n\u00e1lady a motivace. Pokud v\u0161ak tento stav p\u0159etrv\u00e1v\u00e1 bez dostate\u010dn\u00e9 relaxace nebo zotaven\u00ed, m\u016f\u017ee v\u00e9st k vyho\u0159en\u00ed nebo emo\u010dn\u00edmu vy\u010derp\u00e1n\u00ed. <a href=\"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1111\/j.1600-0447.2005.00540.x?casa_token=rG5BTN_AltwAAAAA%3A5VzH55lRpmqof2oMACNkGqtr4P_bTPywY8HzKUFtr_y0oArhUt5KY_LpBhxLosCp2bxaB9x51ZtNtTdu\" target=\"_blank\" rel=\"noopener\"><sup>(21)<\/sup><\/a><\/p>\n<h3>Dopamin a motiva\u010dn\u00ed syst\u00e9m<\/h3>\n<p>Dopamin se pod\u00edl\u00ed tak\u00e9 na motiva\u010dn\u00edm syst\u00e9mu mozku, zejm\u00e9na v prefront\u00e1ln\u00ed k\u016f\u0159e a striatu. Motivace zahrnuje nejen o\u010dek\u00e1v\u00e1n\u00ed odm\u011bny, ale tak\u00e9 snahu o dosa\u017een\u00ed c\u00edl\u016f. Kdy\u017e je hladina dopaminu vysok\u00e1, zvy\u0161uje to v mozku snahu dosahovat c\u00edl\u016f, p\u0159eb\u00edrat iniciativu a zapojovat se do \u010dinnost\u00ed. Tento pocit motivace m\u016f\u017ee v\u00e9st k pozitivn\u00ed n\u00e1lad\u011b, proto\u017ee se jedinci c\u00edt\u00ed pln\u00ed energie a c\u00edlev\u011bdom\u00ed. Kdy\u017e je hladina dopaminu n\u00edzk\u00e1, mohou m\u00edt jedinci pot\u00ed\u017ee s iniciov\u00e1n\u00edm \u010dinnosti, c\u00edt\u00ed se nemotivovan\u00ed a za\u017e\u00edvaj\u00ed stavy n\u00e1lady, jako je apatie nebo lhostejnost. To je \u010dasto pozorov\u00e1no u stav\u016f, jako je deprese nebo \u00fazkost, kdy se i jednoduch\u00e9 \u00fakoly mohou zd\u00e1t zdrcuj\u00edc\u00ed a n\u00e1ro\u010dn\u00e9. <a href=\"https:\/\/psycnet.apa.org\/record\/2009-13385-013\" target=\"_blank\" rel=\"noopener\"><sup>(22)<\/sup><\/a><\/p>\n<h3>Dopamin a \"h\u00e9donistick\u00fd b\u011b\u017eeck\u00fd p\u00e1s\"<\/h3>\n<p>Koncept h\u00e9donick\u00e9ho b\u011bhac\u00edho p\u00e1su nazna\u010duje, \u017ee lid\u00e9 se rychle p\u0159izp\u016fsobuj\u00ed nov\u00fdm \u00farovn\u00edm pot\u011b\u0161en\u00ed nebo uspokojen\u00ed, co\u017e vede k n\u00e1vratu k v\u00fdchoz\u00ed \u00farovni \u0161t\u011bst\u00ed po pozitivn\u00edch nebo negativn\u00edch zku\u0161enostech. Tato adaptace je \u010d\u00e1ste\u010dn\u011b \u0159\u00edzena dopaminem. Po pozitivn\u00edm z\u00e1\u017eitku nebo odm\u011bn\u011b se hladina dopaminu zv\u00fd\u0161\u00ed, ale pom\u011brn\u011b rychle se vr\u00e1t\u00ed na v\u00fdchoz\u00ed \u00farove\u0148. V d\u016fsledku toho mohou lid\u00e9 neust\u00e1le vyhled\u00e1vat nov\u00e9 zdroje pot\u011b\u0161en\u00ed nebo odm\u011bny, aby si udr\u017eeli zv\u00fd\u0161enou hladinu dopaminu a vyhnuli se pocitu nespokojenosti. To m\u016f\u017ee zp\u016fsobit kolob\u011bh v\u00fdkyv\u016f n\u00e1lad, kdy se jedinci hon\u00ed za dal\u0161\u00edm \"opojen\u00edm\" (uvoln\u011bn\u00edm dopaminu), ale nikdy si pln\u011b neudr\u017e\u00ed pozitivn\u00ed n\u00e1ladu. <a href=\"https:\/\/search.proquest.com\/openview\/8b15ad92068863b671a39a53f08793cc\/1.pdf?pq-origsite=gscholar&amp;cbl=35529\" target=\"_blank\" rel=\"noopener\"><sup>(23)<\/sup><\/a><\/p>\n<h3>Dopamin a sp\u00e1nek<\/h3>\n<p>Hladina dopaminu je ovliv\u0148ov\u00e1na denn\u00edm rytmem, kter\u00fd reguluje cykly sp\u00e1nku a bd\u011bn\u00ed. Nedostatek sp\u00e1nku m\u016f\u017ee sn\u00ed\u017eit citlivost dopaminov\u00fdch receptor\u016f, co\u017e zt\u011b\u017euje pocit motivace nebo pozitivn\u00edho nalad\u011bn\u00ed n\u00e1sleduj\u00edc\u00ed den. To m\u016f\u017ee v\u00e9st k poruch\u00e1m n\u00e1lady, jako je podr\u00e1\u017ed\u011bnost nebo sn\u00ed\u017een\u00e1 n\u00e1lada. Na druhou stranu p\u0159im\u011b\u0159en\u00fd odpo\u010dinek a regenerace mohou pomoci udr\u017eet norm\u00e1ln\u00ed funkci dopaminu, stabilizovat n\u00e1ladu a zv\u00fd\u0161it emo\u010dn\u00ed odolnost. <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0168010217300573?casa_token=NjQmjevEnfYAAAAA:nWKc9O-T_1QXoYgFmq9dBtOUB6_1qVgQbcGhcN1RGuKZKV-ZOYT6rPwA6nvnsBMxS-dLm_ELCFY\" target=\"_blank\" rel=\"noopener\"><sup>(24)<\/sup><\/a><\/p>\n<p>&nbsp;<\/p>\n<h2><strong>Stimulace dopaminov\u00fdch receptor\u016f k modulaci dopaminergn\u00edch \u00fa\u010dink\u016f<\/strong><\/h2>\n<p>Dopamin je kl\u00ed\u010dov\u00fd neurotransmiter, kter\u00fd ovliv\u0148uje r\u016fzn\u00e9 mozkov\u00e9 funkce, nap\u0159\u00edklad pohyb, n\u00e1ladu, zpracov\u00e1n\u00ed odm\u011bny a kognitivn\u00ed funkce. Aktivace dopaminov\u00fdch receptor\u016f v r\u016fzn\u00fdch oblastech mozku vede k \u0159ad\u011b fyziologick\u00fdch a behavior\u00e1ln\u00edch reakc\u00ed. Vn\u011bj\u0161\u00ed a vnit\u0159n\u00ed faktory mohou modulovat aktivitu t\u011bchto receptor\u016f, co\u017e zp\u016fsobuje zes\u00edlen\u00ed nebo zeslaben\u00ed dopaminergn\u00edch \u00fa\u010dink\u016f.<\/p>\n<h3><strong>Dopaminergn\u00ed reakce a \u00fa\u010dinky<\/strong><\/h3>\n<p>Dopaminergn\u00ed reakce ozna\u010duje zm\u011bny chov\u00e1n\u00ed a mozkov\u00e9 aktivity, ke kter\u00fdm doch\u00e1z\u00ed po aktivaci dopaminov\u00fdch receptor\u016f. Tyto reakce jsou nezbytn\u00e9 pro mnoho funkc\u00ed, v\u010detn\u011b:<\/p>\n<h4>\u0158\u00edzen\u00ed motoru:<\/h4>\n<p>Dopamin se v\u00fdznamn\u011b pod\u00edl\u00ed na regulaci motoriky, zejm\u00e9na v oblastech, jako je striatum. Poruchy regulace tohoto syst\u00e9mu mohou v\u00e9st k poruch\u00e1m, jako je Parkinsonova choroba, p\u0159i n\u00ed\u017e nedostatek dopaminu zp\u016fsobuje motorick\u00e9 poruchy, jako je t\u0159es, rigidita a bradykineze.<\/p>\n<h4>Odm\u011bna a motivace:<\/h4>\n<p>Dopamin je \u00fast\u0159edn\u00edm prvkem mozkov\u00e9ho syst\u00e9mu odm\u011bny. Kdy\u017e se aktivuj\u00ed dopaminov\u00e9 receptory, vyvol\u00e1v\u00e1 to pocity pot\u011b\u0161en\u00ed a posiluje chov\u00e1n\u00ed, kter\u00e9 vede k odm\u011bn\u011b. Tento mechanismus je nezbytn\u00fd pro motivaci, chov\u00e1n\u00ed zam\u011b\u0159en\u00e9 na c\u00edl a posilov\u00e1n\u00ed \u010dinnost\u00ed, jako je j\u00eddlo, socializace nebo zapojen\u00ed do odm\u011b\u0148uj\u00edc\u00edch z\u00e1\u017eitk\u016f.<\/p>\n<h4>Kognitivn\u00ed funkce a pozornost:<\/h4>\n<p>Dopamin hraje kl\u00ed\u010dovou roli v kognitivn\u00edch funkc\u00edch, jako je pozornost, pam\u011b\u0165 a v\u00fdkonn\u00e9 funkce. Jeho dysregulace je spojena se stavy, jako je porucha pozornosti s hyperaktivitou (ADHD), schizofrenie a dal\u0161\u00ed kognitivn\u00ed poruchy.<\/p>\n<h4>Regulace n\u00e1lady:<\/h4>\n<p>Dopamin se pod\u00edl\u00ed na regulaci n\u00e1lady a n\u00edzk\u00e1 dopaminergn\u00ed aktivita je spojena s p\u0159\u00edznaky deprese, anhedoni\u00ed (nedostatkem pot\u011b\u0161en\u00ed) a n\u00edzkou motivac\u00ed. Naopak zv\u00fd\u0161en\u00e1 dopaminergn\u00ed aktivita m\u016f\u017ee p\u0159isp\u00edvat ke zlep\u0161en\u00ed n\u00e1lady a pohody. <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0165017398000198?casa_token=_WgXUbc67x0AAAAA:gcNArdjm0jqg1-6jul6CJuxKSIHLyEOaAOcEoeOqXy9OgLKmV-UqsQ8ntwPvVH4SXJroJ7BM-7I\" target=\"_blank\" rel=\"noopener\"><sup>(25)<\/sup><\/a><\/p>\n<h3>Vn\u011bj\u0161\u00ed faktory stimuluj\u00edc\u00ed dopaminov\u00e9 receptory<\/h3>\n<p>Vn\u011bj\u0161\u00ed faktory, v\u010detn\u011b l\u00e9k\u016f, l\u00e1tek a podn\u011bt\u016f z prost\u0159ed\u00ed, mohou v\u00fdznamn\u011b ovlivnit aktivitu dopaminov\u00fdch receptor\u016f. Tyto vn\u011bj\u0161\u00ed vlivy \u010dasto vedou k uvoln\u011bn\u00ed dopaminu nebo zesiluj\u00ed jeho p\u016fsoben\u00ed, co\u017e vede k siln\u011bj\u0161\u00ed dopaminergn\u00ed odpov\u011bdi:<\/p>\n<h4>Rekrea\u010dn\u00ed drogy:<\/h4>\n<p>L\u00e1tky jako kokain a metamfetamin zvy\u0161uj\u00ed hladinu dopaminu t\u00edm, \u017ee blokuj\u00ed jeho zp\u011btn\u00e9 vychyt\u00e1v\u00e1n\u00ed nebo zvy\u0161uj\u00ed jeho uvol\u0148ov\u00e1n\u00ed z presynaptick\u00fdch neuron\u016f. Kokain inhibuje dopaminov\u00e9 transport\u00e9ry, \u010d\u00edm\u017e zabra\u0148uje zp\u011btn\u00e9mu vst\u0159eb\u00e1v\u00e1n\u00ed dopaminu do neuron\u016f, zat\u00edmco metamfetamin stimuluje uvol\u0148ov\u00e1n\u00ed dopaminu. Tyto drogy vedou k intenzivn\u00ed euforii a zv\u00fd\u0161en\u00e9 signalizaci odm\u011bny, ale mohou tak\u00e9 zp\u016fsobit z\u00e1vislost a dlouhodobou neurochemickou nerovnov\u00e1hu.<\/p>\n<h4>Nikotin:<\/h4>\n<p>Nikotin stimuluje uvol\u0148ov\u00e1n\u00ed dopaminu prost\u0159ednictv\u00edm nikotinov\u00fdch acetylcholinov\u00fdch receptor\u016f v mozku. Kdy\u017e se nikotin v\u00e1\u017ee na tyto receptory, nep\u0159\u00edmo zvy\u0161uje aktivitu dopaminu, co\u017e p\u0159isp\u00edv\u00e1 k p\u0159\u00edjemn\u00fdm a n\u00e1vykov\u00fdm vlastnostem u\u017e\u00edv\u00e1n\u00ed tab\u00e1ku.<\/p>\n<h4>Kofein:<\/h4>\n<p>Kofein p\u016fsob\u00ed p\u0159edev\u0161\u00edm tak, \u017ee blokuje adenosinov\u00e9 receptory, co\u017e n\u00e1sledn\u011b zvy\u0161uje uvol\u0148ov\u00e1n\u00ed dopaminu. To vede ke zv\u00fd\u0161en\u00ed bd\u011blosti, zlep\u0161en\u00ed n\u00e1lady a do\u010dasn\u00e9mu zv\u00fd\u0161en\u00ed energie a motivace.<\/p>\n<h4>Alkohol:<\/h4>\n<p>Hladinu dopaminu ovliv\u0148uje tak\u00e9 konzumace alkoholu. M\u016f\u017ee zv\u00fd\u0161it uvol\u0148ov\u00e1n\u00ed dopaminu, zejm\u00e9na v oblastech zapojen\u00fdch do zpracov\u00e1n\u00ed odm\u011bny, jako je nucleus accumbens. Toto zv\u00fd\u0161en\u00ed p\u0159isp\u00edv\u00e1 k p\u0159\u00edjemn\u00fdm pocit\u016fm spojen\u00fdm s pit\u00edm a posiluje konzumaci alkoholu, co\u017e m\u016f\u017ee v\u00e9st k z\u00e1vislosti. <a href=\"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/abs\/10.1002\/jcph.1918\" target=\"_blank\" rel=\"noopener\"><sup>(26)<\/sup><\/a><\/p>\n<h3>Vnit\u0159n\u00ed faktory stimuluj\u00edc\u00ed dopaminov\u00e9 receptory<\/h3>\n<p>Krom\u011b vn\u011bj\u0161\u00edch podn\u011bt\u016f reguluj\u00ed dopaminergn\u00ed syst\u00e9m tak\u00e9 vnit\u0159n\u00ed procesy v t\u011ble. Vnit\u0159n\u00ed faktory, jako je motivace, stres a hormon\u00e1ln\u00ed v\u00fdkyvy, mohou ovliv\u0148ovat aktivitu dopaminov\u00fdch receptor\u016f:<\/p>\n<h4>Reakce na stres:<\/h4>\n<p>Akutn\u00ed stres m\u016f\u017ee v\u00e9st k uvoln\u011bn\u00ed dopaminu jako sou\u010d\u00e1sti reakce t\u011bla na boj nebo \u00fat\u011bk. Zat\u00edmco uvol\u0148ov\u00e1n\u00ed dopaminu p\u0159i stresu m\u016f\u017ee kr\u00e1tkodob\u011b zv\u00fd\u0161it bd\u011blost a koncentraci, chronick\u00fd stres m\u016f\u017ee naru\u0161it norm\u00e1ln\u00ed dopaminergn\u00ed funkci a potenci\u00e1ln\u011b p\u0159isp\u011bt k poruch\u00e1m n\u00e1lady, z\u00e1vislosti nebo kognitivn\u00edm poruch\u00e1m. <a href=\"\/cs\/Sinclair,%20D.,%20Purves-Tyson,%20T.%20D.,%20Allen,%20K.%20M.,%20&amp;%20Weickert,%20C.%20S.%20(2014).%20Impacts%20of%20stress%20and%20sex%20hormones%20on%20dopamine%20neurotransmission%20in%20the%20adolescent%20brain.%20Psychopharmacology,%20231,%201581-1599.\/\"><sup>(27)<\/sup><\/a><\/p>\n<h4>Hormon\u00e1ln\u00ed vlivy:<\/h4>\n<p>Hormony, zejm\u00e9na estrogen a testosteron, mohou modulovat aktivitu dopaminov\u00fdch receptor\u016f. Nap\u0159\u00edklad vy\u0161\u0161\u00ed hladiny estrogenu jsou spojeny se zv\u00fd\u0161en\u00fdm uvol\u0148ov\u00e1n\u00edm dopaminu, tak\u017ee \u017eeny mohou b\u011bhem ur\u010dit\u00fdch f\u00e1z\u00ed menstrua\u010dn\u00edho cyklu poci\u0165ovat v\u00fdkyvy n\u00e1lad nebo zm\u011bny motivace. <a href=\"\/cs\/Sinclair,%20D.,%20Purves-Tyson,%20T.%20D.,%20Allen,%20K.%20M.,%20&amp;%20Weickert,%20C.%20S.%20(2014).%20Impacts%20of%20stress%20and%20sex%20hormones%20on%20dopamine%20neurotransmission%20in%20the%20adolescent%20brain.%20Psychopharmacology,%20231,%201581-1599.\/\"><sup>(27)<\/sup><\/a><\/p>\n<h3>Synergick\u00e9 \u00fa\u010dinky a kombinovan\u00e9 podn\u011bty<\/h3>\n<p>N\u011bkdy se r\u016fzn\u00e9 vn\u011bj\u0161\u00ed a vnit\u0159n\u00ed faktory vz\u00e1jemn\u011b ovliv\u0148uj\u00ed a vytv\u00e1\u0159ej\u00ed synergickou dopaminergn\u00ed reakci, kter\u00e1 zesiluje \u00fa\u010dinky uvol\u0148ov\u00e1n\u00ed dopaminu. Nap\u0159\u00edklad kombinace cvi\u010den\u00ed se soci\u00e1ln\u00edmi interakcemi m\u016f\u017ee v\u00e9st ke zv\u00fd\u0161en\u00e9 dopaminergn\u00ed odezv\u011b, proto\u017ee ob\u011b \u010dinnosti samostatn\u011b zvy\u0161uj\u00ed uvol\u0148ov\u00e1n\u00ed dopaminu. Tento synergick\u00fd efekt je zvl\u00e1\u0161t\u011b prosp\u011b\u0161n\u00fd pro zlep\u0161en\u00ed n\u00e1lady, motivace a kognitivn\u00edch funkc\u00ed.<\/p>\n<p>Kombinace l\u00e1tek, jako je kofein a nikotin, m\u016f\u017ee nav\u00edc v\u00e9st ke zv\u00fd\u0161en\u00e9 bd\u011blosti a siln\u011bj\u0161\u00edmu pocitu odm\u011bny, proto\u017ee ob\u011b l\u00e1tky stimuluj\u00ed uvol\u0148ov\u00e1n\u00ed dopaminu r\u016fzn\u00fdmi mechanismy. Opakovan\u00e9 nebo nadm\u011brn\u00e9 u\u017e\u00edv\u00e1n\u00ed t\u011bchto l\u00e1tek v\u0161ak m\u016f\u017ee v\u00e9st k z\u00e1vislosti nebo n\u00e1vyku v d\u016fsledku nadm\u011brn\u00e9 stimulace dopaminergn\u00edho syst\u00e9mu. <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/001429999290616C\" target=\"_blank\" rel=\"noopener\"><sup>(28)<\/sup><\/a><\/p>\n<p>&nbsp;<\/p>\n<h2>Inhibice zp\u011btn\u00e9ho vychyt\u00e1v\u00e1n\u00ed dopaminu<\/h2>\n<p>Za norm\u00e1ln\u00edch podm\u00ednek se dopamin uvol\u0148uje z presynaptick\u00fdch neuron\u016f do synaptick\u00e9 \u0161t\u011brbiny, kde se v\u00e1\u017ee na dopaminov\u00e9 receptory na postsynaptick\u00fdch neuronech a vyvol\u00e1v\u00e1 r\u016fzn\u00e9 \u00fa\u010dinky. Jakmile dopamin dokon\u010d\u00ed svou signaliza\u010dn\u00ed \u00falohu, je za norm\u00e1ln\u00edch okolnost\u00ed zp\u011btn\u011b absorbov\u00e1n do presynaptick\u00e9ho neuronu. Pokud je v\u0161ak zp\u011btn\u00e9 vychyt\u00e1v\u00e1n\u00ed dopaminu inhibov\u00e1no n\u011bkter\u00fdmi l\u00e1tkami nebo l\u00e9ky, z\u016fst\u00e1v\u00e1 dopamin v synaptick\u00e9 \u0161t\u011brbin\u011b d\u00e9le, co\u017e vede k prodlou\u017een\u00e9 stimulaci dopaminov\u00fdch receptor\u016f. Tato zes\u00edlen\u00e1 dopaminergn\u00ed signalizace m\u016f\u017ee m\u00edt za n\u00e1sledek siln\u011bj\u0161\u00ed pocity euforie, zv\u00fd\u0161enou motivaci, zv\u00fd\u0161enou koncentraci a dal\u0161\u00ed \u00fa\u010dinky v z\u00e1vislosti na posti\u017een\u00e9 oblasti mozku. <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0149763405000837?casa_token=0V8nBjY-5BsAAAAA:xKohNM65h2slKNrcSMVT7__lwfPrZDIOVQOcDRI9XdkuefcQ2dhXgl2lIaBSf2V3HeCgzwR03eQ\" target=\"_blank\" rel=\"noopener\"><sup>(29)<\/sup><\/a><\/p>\n<h3>Mechanismus inhibice zp\u011btn\u00e9ho vychyt\u00e1v\u00e1n\u00ed dopaminu<\/h3>\n<p>Inhibitory zp\u011btn\u00e9ho vychyt\u00e1v\u00e1n\u00ed dopaminu (DRI) funguj\u00ed tak, \u017ee blokuj\u00ed dopaminov\u00fd transport\u00e9r (DAT), protein zodpov\u011bdn\u00fd za transport dopaminu zp\u011bt do presynaptick\u00e9ho neuronu. Zabr\u00e1n\u011bn\u00edm t\u00e9to zp\u011btn\u00e9 absorpce z\u016fst\u00e1v\u00e1 dopamin d\u00e9le v synaps\u00edch, co\u017e vede k prodlou\u017een\u00e9 aktivaci dopaminov\u00fdch receptor\u016f . Tato zv\u00fd\u0161en\u00e1 dostupnost dopaminu zvy\u0161uje \u00fa\u010dinky neurotransmiteru na n\u00e1ladu, kognitivn\u00ed funkce a motorickou kontrolu.<\/p>\n<h3>L\u00e1tky, kter\u00e9 inhibuj\u00ed zp\u011btn\u00e9 vychyt\u00e1v\u00e1n\u00ed dopaminu<\/h3>\n<p>N\u011bkolik l\u00e1tek, jak l\u00e9\u010div\u00fdch, tak rekrea\u010dn\u00edch, p\u016fsob\u00ed jako inhibitory zp\u011btn\u00e9ho vychyt\u00e1v\u00e1n\u00ed dopaminu a ovliv\u0148uj\u00ed dopaminergn\u00ed syst\u00e9m r\u016fzn\u00fdmi zp\u016fsoby:<\/p>\n<h4><strong>Kokain<\/strong>:<\/h4>\n<p>Kokain, jeden z nejzn\u00e1m\u011bj\u0161\u00edch inhibitor\u016f zp\u011btn\u00e9ho vychyt\u00e1v\u00e1n\u00ed dopaminu, blokuje DAT, co\u017e vede k dramatick\u00e9mu zv\u00fd\u0161en\u00ed hladiny dopaminu v synaptick\u00e9 \u0161t\u011brbin\u011b. V\u00fdsledkem je intenzivn\u00ed pocit euforie, zv\u00fd\u0161en\u00e1 energie a zv\u00fd\u0161en\u00e1 bd\u011blost. Chronick\u00e9 u\u017e\u00edv\u00e1n\u00ed kokainu v\u0161ak m\u016f\u017ee v\u00e9st k z\u00e1vislosti a dlouhodob\u00e9mu naru\u0161en\u00ed dopaminov\u00e9 signalizace.<\/p>\n<h4>Amfetaminy:<\/h4>\n<p>Drogy jako metamfetamin a ext\u00e1ze rovn\u011b\u017e inhibuj\u00ed zp\u011btn\u00e9 vychyt\u00e1v\u00e1n\u00ed dopaminu, ale mohou nav\u00edc zvy\u0161ovat uvol\u0148ov\u00e1n\u00ed dopaminu z presynaptick\u00fdch neuron\u016f. Toto dvoj\u00ed p\u016fsoben\u00ed vede k v\u00fdrazn\u011bj\u0161\u00edmu zv\u00fd\u0161en\u00ed hladiny dopaminu, co\u017e p\u0159isp\u00edv\u00e1 ke stimula\u010dn\u00edm \u00fa\u010dink\u016fm a n\u00e1vykov\u00e9mu potenci\u00e1lu t\u011bchto l\u00e1tek.<\/p>\n<h4>N\u011bkter\u00e1 antidepresiva:<\/h4>\n<p>N\u011bkter\u00e9 selektivn\u00ed inhibitory zp\u011btn\u00e9ho vychyt\u00e1v\u00e1n\u00ed serotoninu, noradrenalinu a dopaminu (SSNDRI), jako je bupropion, se terapeuticky pou\u017e\u00edvaj\u00ed k l\u00e9\u010db\u011b deprese a ADHD. Tyto l\u00e9ky inhibuj\u00ed zp\u011btn\u00e9 vychyt\u00e1v\u00e1n\u00ed dopaminu (a n\u011bkdy i serotoninu a noradrenalinu), \u010d\u00edm\u017e zvy\u0161uj\u00ed dostupnost dopaminu a zlep\u0161uj\u00ed n\u00e1ladu, koncentraci a motivaci.<\/p>\n<h4>Methylfenid\u00e1t:<\/h4>\n<p>Methylfenid\u00e1t (Ritalin), kter\u00fd se b\u011b\u017en\u011b pou\u017e\u00edv\u00e1 k l\u00e9\u010db\u011b ADHD, inhibuje zp\u011btn\u00e9 vychyt\u00e1v\u00e1n\u00ed dopaminu, co\u017e vede ke zv\u00fd\u0161en\u00ed dopaminergn\u00ed aktivity v oblastech mozku, kter\u00e9 se pod\u00edlej\u00ed na koncentraci, pozornosti a kontrole chov\u00e1n\u00ed. <a href=\"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/article-abstract\/2608759\" target=\"_blank\" rel=\"noopener\"><sup>(30)<\/sup><\/a><\/p>\n<h3>\u00da\u010dinky inhibice zp\u011btn\u00e9ho vychyt\u00e1v\u00e1n\u00ed dopaminu<\/h3>\n<p>Inhibice zp\u011btn\u00e9ho vychyt\u00e1v\u00e1n\u00ed dopaminu m\u016f\u017ee m\u00edt n\u011bkolik v\u00fdznamn\u00fdch \u00fa\u010dink\u016f na mozek a chov\u00e1n\u00ed:<\/p>\n<h4>Zv\u00fd\u0161en\u00e1 citlivost na odm\u011bny:<\/h4>\n<p>Proto\u017ee dopamin je \u00fast\u0159edn\u00edm prvkem mozkov\u00e9ho syst\u00e9mu odm\u011bny, inhibice jeho zp\u011btn\u00e9ho vychyt\u00e1v\u00e1n\u00ed vede ke zv\u00fd\u0161en\u00ed pocitu pot\u011b\u0161en\u00ed a odm\u011bny. Proto jsou drogy jako kokain a amfetamin spojov\u00e1ny s intenzivn\u00ed eufori\u00ed a maj\u00ed vysok\u00fd potenci\u00e1l ke zneu\u017e\u00edv\u00e1n\u00ed.<\/p>\n<h4>Zv\u00fd\u0161en\u00e1 koncentrace a bd\u011blost:<\/h4>\n<p>Inhibitory zp\u011btn\u00e9ho vychyt\u00e1v\u00e1n\u00ed mohou zv\u00fd\u0161it dostupnost dopaminu v oblastech mozku spojen\u00fdch s pozornost\u00ed a v\u00fdkonn\u00fdmi funkcemi, co\u017e je prosp\u011b\u0161n\u00e9 p\u0159i l\u00e9\u010db\u011b stav\u016f, jako je ADHD.<\/p>\n<h4>Zlep\u0161en\u00ed n\u00e1lady:<\/h4>\n<p>Inhibitory zp\u011btn\u00e9ho vychyt\u00e1v\u00e1n\u00ed dopaminu mohou zv\u00fd\u0161en\u00edm dopaminergn\u00ed aktivity zlep\u0161it n\u00e1ladu a zm\u00edrnit p\u0159\u00edznaky deprese. Na tomto z\u00e1klad\u011b se n\u011bkter\u00e9 z t\u011bchto inhibitor\u016f pou\u017e\u00edvaj\u00ed jako antidepresiva. <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0149763405000837?casa_token=0V8nBjY-5BsAAAAA:xKohNM65h2slKNrcSMVT7__lwfPrZDIOVQOcDRI9XdkuefcQ2dhXgl2lIaBSf2V3HeCgzwR03eQ\" target=\"_blank\" rel=\"noopener\"><sup>(29)<\/sup><\/a><\/p>\n<h2>Dopl\u0148ky ke zv\u00fd\u0161en\u00ed hladiny dopaminu<\/h2>\n<p>Je zn\u00e1mo n\u011bkolik dopl\u0148k\u016f, kter\u00e9 podporuj\u00ed produkci, uvol\u0148ov\u00e1n\u00ed nebo aktivitu dopaminov\u00fdch receptor\u016f v mozku. Tyto dopl\u0148ky mohou b\u00fdt prosp\u011b\u0161n\u00e9 pro zlep\u0161en\u00ed n\u00e1lady, motivace, kognitivn\u00edch funkc\u00ed a celkov\u00e9 pohody, zejm\u00e9na u lid\u00ed s n\u00edzkou dopaminergn\u00ed aktivitou, jako jsou lid\u00e9 trp\u00edc\u00ed depresemi nebo poruchami pozornosti.<\/p>\n<h4>L-tyrosin:<\/h4>\n<p>L-tyrosin je aminokyselina, kter\u00e1 slou\u017e\u00ed jako prekurzor dopaminu. P\u0159em\u011b\u0148uje se na L-DOPA, kter\u00e1 se n\u00e1sledn\u011b syntetizuje na dopamin. Suplementace L-tyrosinem m\u016f\u017ee pomoci zv\u00fd\u0161it hladinu dopaminu, zejm\u00e9na v obdob\u00ed stresu, \u00fanavy nebo du\u0161evn\u00edho nap\u011bt\u00ed, proto\u017ee zvy\u0161uje synt\u00e9zu dopaminu. <a href=\"https:\/\/neurolaunch.com\/dopamine-brain-food-natural-stacks\/\" target=\"_blank\" rel=\"noopener\"><sup>(31)<\/sup><\/a><\/p>\n<h4>Rhodiola Rosea:<\/h4>\n<p>Rhodiola je adaptogen, kter\u00fd pom\u00e1h\u00e1 sni\u017eovat stres a \u00fanavu. Dok\u00e1\u017ee zv\u00fd\u0161it citlivost dopaminov\u00fdch receptor\u016f a zv\u00fd\u0161it produkci dopaminu, co\u017e vede ke zlep\u0161en\u00ed n\u00e1lady a du\u0161evn\u00ed v\u00fdkonnosti ve stresov\u00fdch podm\u00ednk\u00e1ch. <a href=\"https:\/\/www.mdpi.com\/2076-3921\/12\/8\/1603\" target=\"_blank\" rel=\"noopener\"><sup>(32)<\/sup><\/a><\/p>\n<h4><strong>Omega-3 mastn\u00e9 kyseliny<\/strong>:<\/h4>\n<p>Bylo prok\u00e1z\u00e1no, \u017ee omega-3 mastn\u00e9 kyseliny, kter\u00e9 se nach\u00e1zej\u00ed v ryb\u00edm tuku a n\u011bkter\u00fdch rostlinn\u00fdch olej\u00edch, zvy\u0161uj\u00ed hustotu dopaminov\u00fdch receptor\u016f a posiluj\u00ed dopaminergn\u00ed signalizaci. Tyto zdrav\u00e9 tuky podporuj\u00ed celkov\u00e9 zdrav\u00ed mozku a funkci dopaminu. <a href=\"https:\/\/neurolaunch.com\/dopamine-brain-food-natural-stacks\/\" target=\"_blank\" rel=\"noopener\"><sup>(31)<\/sup><\/a><\/p>\n<h4><strong>Kurkumin<\/strong>:<\/h4>\n<p>\u00da\u010dinn\u00e1 l\u00e1tka kurkumy, kurkumin, m\u016f\u017ee pomoci zv\u00fd\u0161it hladinu dopaminu t\u00edm, \u017ee sni\u017euje z\u00e1n\u011bt a podporuje produkci neurotrofick\u00e9ho faktoru odvozen\u00e9ho od mozku (BDNF), kter\u00fd podporuje r\u016fst neuron\u016f produkuj\u00edc\u00edch dopamin. <a href=\"https:\/\/www.mdpi.com\/2076-3921\/12\/8\/1603\" target=\"_blank\" rel=\"noopener\"><sup>(32)<\/sup><\/a><\/p>\n<h4><strong>Vitamin B6<\/strong>:<\/h4>\n<p>Bylo prok\u00e1z\u00e1no, \u017ee vitamin B6 hraje roli v regulaci dopaminov\u00fdch receptor\u016f. Nedostatek vitaminu B6 m\u016f\u017ee zhor\u0161it funkci dopaminov\u00fdch receptor\u016f, co\u017e vede k poruch\u00e1m n\u00e1lady a kognitivn\u00edm probl\u00e9m\u016fm. Suplementace multivitam\u00edny m\u016f\u017ee pomoci udr\u017eet zdrav\u00e9 hladiny dopaminu. <a href=\"https:\/\/neurolaunch.com\/dopamine-brain-food-natural-stacks\/\" target=\"_blank\" rel=\"noopener\"><sup>(31)<\/sup><\/a><\/p>\n<p>&nbsp;<\/p>\n<h2>Vliv bromantanu na hladinu dopaminu<\/h2>\n<p>Bromantan je nootropikum a adaptogen se stimula\u010dn\u00edmi \u00fa\u010dinky, kter\u00fd se \u010dasto pou\u017e\u00edv\u00e1 ke zv\u00fd\u0161en\u00ed du\u0161evn\u00ed v\u00fdkonnosti, sn\u00ed\u017een\u00ed \u00fanavy a zlep\u0161en\u00ed kognitivn\u00edch funkc\u00ed. Bromantan, p\u016fvodn\u011b vyvinut\u00fd v Rusku k l\u00e9\u010db\u011b astenie (stav fyzick\u00e9 a du\u0161evn\u00ed \u00fanavy), si z\u00edskal oblibu jako prost\u0159edek zlep\u0161uj\u00edc\u00ed kognitivn\u00ed funkce d\u00edky sv\u00e9 schopnosti ovliv\u0148ovat r\u016fzn\u00e9 neurotransmiterov\u00e9 syst\u00e9my, v\u010detn\u011b dopaminu. <a href=\"https:\/\/www.ijest.org\/nootropics\/bromantane\/\" target=\"_blank\" rel=\"noopener\"><sup>(33)<\/sup><\/a><\/p>\n<p>Bromantan m\u00e1 jedine\u010dn\u00fd mechanismus \u00fa\u010dinku. Je klasifikov\u00e1n jako l\u00e1tka bez n\u00e1vykov\u00e9ho potenci\u00e1lu nebo v\u00fdrazn\u00fdch stimula\u010dn\u00edch \u00fa\u010dink\u016f pozorovan\u00fdch u jin\u00fdch amfetamin\u016f. Prim\u00e1rn\u00edm \u00fa\u010dinkem bromantanu na hladinu dopaminu je zv\u00fd\u0161en\u00ed synt\u00e9zy dopaminu zv\u00fd\u0161en\u00edm aktivity tyrosinhydroxyl\u00e1zy, enzymu odpov\u011bdn\u00e9ho za p\u0159em\u011bnu tyrosinu na L-DOPA (prekurzor dopaminu). To p\u0159isp\u00edv\u00e1 ke zv\u00fd\u0161en\u00ed hladiny dopaminu v mozku. Zd\u00e1 se, \u017ee bromantan m\u00e1 tak\u00e9 modula\u010dn\u00ed \u00fa\u010dinek na dopaminov\u00e9 receptory, \u010d\u00edm\u017e zlep\u0161uje citlivost receptor\u016f, ani\u017e by doch\u00e1zelo k jejich nadm\u011brn\u00e9 stimulaci. Dopaminergn\u00ed \u00fa\u010dinky bromantanu mohou p\u0159isp\u00edvat ke zlep\u0161en\u00ed kognitivn\u00edch funkc\u00ed, jako je pozornost, u\u010den\u00ed a pam\u011b\u0165. To je zvl\u00e1\u0161t\u011b prosp\u011b\u0161n\u00e9 pro ty, kte\u0159\u00ed poci\u0165uj\u00ed kognitivn\u00ed \u00fanavu, nebo pro ty, kte\u0159\u00ed vy\u017eaduj\u00ed du\u0161evn\u00ed jasnost b\u011bhem \u00fakol\u016f pod vysok\u00fdm tlakem. Na rozd\u00edl od tradi\u010dn\u00edch stimulanci\u00ed, jako je amfetamin nebo methylfenid\u00e1t, v\u0161ak bromantan nevyvol\u00e1v\u00e1 stejnou m\u00edru nervozity nebo nadm\u011brn\u00e9 stimulace, tak\u017ee je jemn\u011bj\u0161\u00edm posilova\u010dem kognitivn\u00edch funkc\u00ed. <a href=\"https:\/\/www.ijest.org\/nootropics\/bromantane\/\" target=\"_blank\" rel=\"noopener\"><sup>(33)<\/sup><\/a><\/p>\n<p>Jedn\u00edm z kl\u00ed\u010dov\u00fdch p\u0159\u00ednos\u016f bromantanu jsou jeho adaptogenn\u00ed vlastnosti. Nejen\u017ee zvy\u0161uje hladinu dopaminu, ale tak\u00e9 podporuje rovnov\u00e1hu v nervov\u00e9m syst\u00e9mu. Tento dvoj\u00ed \u00fa\u010dinek pom\u00e1h\u00e1 sni\u017eovat stres a \u00fazkost a z\u00e1rove\u0148 zvy\u0161uje du\u0161evn\u00ed a fyzickou v\u00fdkonnost. Navzdory sv\u00e9 schopnosti zvy\u0161ovat dopaminergn\u00ed aktivitu nen\u00ed bromantan pova\u017eov\u00e1n za n\u00e1vykov\u00fd a jeho u\u017e\u00edv\u00e1n\u00ed nezp\u016fsobuje stejn\u00fd \"crash\" nebo z\u00e1vislost spojenou s jin\u00fdmi stimulanty. Stru\u010dn\u011b \u0159e\u010deno, bromantan zvy\u0161uje hladinu dopaminu prost\u0159ednictv\u00edm inhibice zp\u011btn\u00e9ho vychyt\u00e1v\u00e1n\u00ed dopaminu a zv\u00fd\u0161en\u00e9 synt\u00e9zy, co\u017e vede ke zlep\u0161en\u00ed kognitivn\u00edch funkc\u00ed, du\u0161evn\u00ed jasnosti a sn\u00ed\u017een\u00ed \u00fanavy. Jeho \u00fa\u010dinky na dopamin jsou jemn\u011bj\u0161\u00ed ne\u017e u tradi\u010dn\u00edch stimulant\u016f a m\u00e1 adaptogenn\u00ed vlastnosti, kter\u00e9 pom\u00e1haj\u00ed udr\u017eovat vyv\u00e1\u017een\u00fd dopaminergn\u00ed syst\u00e9m. <a href=\"https:\/\/www.ijest.org\/nootropics\/bromantane\/\" target=\"_blank\" rel=\"noopener\"><sup>(33)<\/sup><\/a><\/p>\n<h2>Vliv aniracetamu na hladinu dopaminu<\/h2>\n<p>Aniracetam je nootropikum ze skupiny racetam\u016f, kter\u00e9 se b\u011b\u017en\u011b pou\u017e\u00edv\u00e1 ke zlep\u0161en\u00ed kognitivn\u00edch funkc\u00ed, pos\u00edlen\u00ed pam\u011bti a zv\u00fd\u0161en\u00ed koncentrace. A\u010dkoli se p\u0159edpokl\u00e1d\u00e1, \u017ee jeho hlavn\u00ed \u00fa\u010dinky jsou na AMPA receptory (kter\u00e9 se pod\u00edlej\u00ed na synaptick\u00e9 plasticit\u011b a u\u010den\u00ed), aniracetam tak\u00e9 ovliv\u0148uje hladiny dopaminu a dopaminergn\u00ed aktivitu v mozku. P\u0159edpokl\u00e1d\u00e1 se, \u017ee aniracetam nep\u0159\u00edmo ovliv\u0148uje hladiny dopaminu t\u00edm, \u017ee zvy\u0161uje celkovou aktivitu glutam\u00e1tergn\u00edho syst\u00e9mu, co\u017e m\u016f\u017ee n\u00e1sledn\u011b ovlivnit dopaminovou signalizaci. Konkr\u00e9tn\u011b se p\u0159edpokl\u00e1d\u00e1, \u017ee aniracetam moduluje dopaminergn\u00ed neurotransmisi ovlivn\u011bn\u00edm hladiny cAMP (cyklick\u00e9ho adenosinmonofosf\u00e1tu). cAMP je sekund\u00e1rn\u00ed posel, kter\u00fd hraje kl\u00ed\u010dovou roli v regulaci dopaminov\u00fdch receptor\u016f a uvol\u0148ov\u00e1n\u00ed dopaminu. Zv\u00fd\u0161en\u00edm produkce cAMP m\u016f\u017ee aniracetam zv\u00fd\u0161it citlivost dopaminov\u00fdch receptor\u016f, tak\u017ee mozek l\u00e9pe reaguje na dopamin. Krom\u011b toho bylo prok\u00e1z\u00e1no, \u017ee aniracetam zvy\u0161uje uvol\u0148ov\u00e1n\u00ed dopaminu v ur\u010dit\u00fdch oblastech mozku, v\u010detn\u011b striata, kter\u00e9 se pod\u00edl\u00ed na zpracov\u00e1n\u00ed odm\u011bny a \u0159\u00edzen\u00ed motoriky. To m\u016f\u017ee v\u00e9st ke zv\u00fd\u0161en\u00ed motivace, n\u00e1lady a celkov\u00e9 kognitivn\u00ed v\u00fdkonnosti, zejm\u00e9na p\u0159i \u00fakolech vy\u017eaduj\u00edc\u00edch soust\u0159ed\u011bn\u00ed nebo du\u0161evn\u00ed \u00fasil\u00ed. Tento \u00fa\u010dinek m\u016f\u017ee tak\u00e9 vysv\u011btlovat, pro\u010d n\u011bkte\u0159\u00ed u\u017eivatel\u00e9 p\u0159i u\u017e\u00edv\u00e1n\u00ed aniracetamu uv\u00e1d\u011bj\u00ed zlep\u0161en\u00ed n\u00e1lady a du\u0161evn\u00ed jasnosti, proto\u017ee dopamin je kl\u00ed\u010dov\u00fdm hr\u00e1\u010dem v regulaci n\u00e1lady. <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0006899301029390?casa_token=L4sginq_LmgAAAAA:1Ov9i895A6KNRPNajs5G7t9B2VNCtGoAk9Q3nxRJ1zSggnamw2EArQG0uKPf4ONsg0epNJPjQpg\" target=\"_blank\" rel=\"noopener\"><sup>(34)<\/sup><\/a><\/p>\n<p>Aniracetam m\u00e1 tak\u00e9 neuroprotektivn\u00ed \u00fa\u010dinky a m\u016f\u017ee pom\u00e1hat udr\u017eovat dopaminergn\u00ed funkci v pr\u016fb\u011bhu \u010dasu. N\u011bkter\u00e9 studie nazna\u010duj\u00ed, \u017ee m\u016f\u017ee chr\u00e1nit dopaminov\u00e9 receptory p\u0159ed oxida\u010dn\u00edm po\u0161kozen\u00edm, co\u017e je d\u016fle\u017eit\u00e9 zejm\u00e9na pro udr\u017een\u00ed zdrav\u00e9 dopaminov\u00e9 signalizace s p\u0159ib\u00fdvaj\u00edc\u00edm v\u011bkem. Tato neuroprotektivn\u00ed vlastnost m\u016f\u017ee pomoci p\u0159edch\u00e1zet zhor\u0161ov\u00e1n\u00ed kognitivn\u00edch funkc\u00ed souvisej\u00edc\u00edch s v\u011bkem a podporovat dlouhodobou dopaminergn\u00ed funkci. Pokud jde o n\u00e1ladu, zv\u00fd\u0161en\u00ed dopaminov\u00e9 aktivity zp\u016fsoben\u00e9 aniracetamem m\u016f\u017ee pomoci zm\u00edrnit p\u0159\u00edznaky deprese, \u00fazkosti nebo n\u00edzk\u00e9 motivace. Zv\u00fd\u0161en\u00edm dopaminergn\u00ed signalizace m\u016f\u017ee podpo\u0159it pohodu a motivaci, kter\u00e9 jsou \u010dasto naru\u0161eny u stav\u016f spojen\u00fdch s dopaminergn\u00ed dysfunkc\u00ed. <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0006899301029390?casa_token=L4sginq_LmgAAAAA:1Ov9i895A6KNRPNajs5G7t9B2VNCtGoAk9Q3nxRJ1zSggnamw2EArQG0uKPf4ONsg0epNJPjQpg\" target=\"_blank\" rel=\"noopener\"><sup>(34)<\/sup><\/a><\/p>\n<p>Aniracetam v\u0161ak z\u0159ejm\u011b nestimuluje dopaminergn\u00ed syst\u00e9m tak, jako p\u0159\u00edm\u00e9 inhibitory zp\u011btn\u00e9ho vychyt\u00e1v\u00e1n\u00ed dopaminu nebo stimulanty, jako je amfetamin. \u00da\u010dinky na dopamin jsou obecn\u011b jemn\u00e9 a zam\u011b\u0159uj\u00ed se sp\u00ed\u0161e na modulaci citlivosti dopaminov\u00fdch receptor\u016f ne\u017e na zp\u016fsoben\u00ed velk\u00e9ho zv\u00fd\u0161en\u00ed uvol\u0148ov\u00e1n\u00ed dopaminu. Aniracetam m\u00e1 tedy m\u00edrn\u00fd, ale p\u0159\u00edzniv\u00fd \u00fa\u010dinek na hladinu dopaminu t\u00edm, \u017ee zvy\u0161uje uvol\u0148ov\u00e1n\u00ed dopaminu a zvy\u0161uje citlivost receptor\u016f. Napom\u00e1h\u00e1 kognitivn\u00edm funkc\u00edm a n\u00e1lad\u011b t\u00edm, \u017ee zlep\u0161uje dopaminergn\u00ed signalizaci v mozku, a\u010dkoli jeho hlavn\u00ed \u00fa\u010dinky jsou na glutam\u00e1tergn\u00ed syst\u00e9m. <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0006899301029390?casa_token=L4sginq_LmgAAAAA:1Ov9i895A6KNRPNajs5G7t9B2VNCtGoAk9Q3nxRJ1zSggnamw2EArQG0uKPf4ONsg0epNJPjQpg\" target=\"_blank\" rel=\"noopener\"><sup>(34)<\/sup><\/a><\/p>\n<h2>Vliv teakrinu na hladinu dopaminu<\/h2>\n<p>Theakrin (zn\u00e1m\u00fd tak\u00e9 jako theakrin) je p\u0159irozen\u011b se vyskytuj\u00edc\u00ed alkaloid, kter\u00fd se nach\u00e1z\u00ed v \u010daji a k\u00e1v\u011b Kucha a kter\u00fd se \u010dasto pou\u017e\u00edv\u00e1 pro sv\u00e9 stimula\u010dn\u00ed a nootropn\u00ed \u00fa\u010dinky. A\u010dkoli je theakrin strukturn\u011b podobn\u00fd kofeinu, m\u00e1 odli\u0161n\u00fd farmakologick\u00fd profil, zejm\u00e9na pokud jde o jeho \u00fa\u010dinky na dopamin a dal\u0161\u00ed neurotransmitery. Theakrin ovliv\u0148uje dopamin p\u0159edev\u0161\u00edm prost\u0159ednictv\u00edm sv\u00e9 schopnosti zvy\u0161ovat uvol\u0148ov\u00e1n\u00ed dopaminu v ur\u010dit\u00fdch oblastech mozku. Stejn\u011b jako kofein p\u016fsob\u00ed theakrin blokov\u00e1n\u00edm adenosinov\u00fdch receptor\u016f, kter\u00e9 se pod\u00edlej\u00ed na podpo\u0159e relaxace a sp\u00e1nku. Antagonizac\u00ed t\u011bchto receptor\u016f theakrin podporuje bd\u011blost a ostra\u017eitost. Theakrin v\u0161ak nezp\u016fsobuje takovou m\u00edru nervozity nebo poklesu energie, jakou m\u016f\u017ee zp\u016fsobit kofein. <a href=\"https:\/\/magistralbr.caldic.com\/storage\/product-files\/624080992.pdf\" target=\"_blank\" rel=\"noopener\"><sup>(35)<\/sup><\/a><\/p>\n<p>Jedn\u00edm z kl\u00ed\u010dov\u00fdch zp\u016fsob\u016f, jak theakrin ovliv\u0148uje dopamin, je prost\u0159ednictv\u00edm dopaminov\u00fdch D2 receptor\u016f. V\u00fdzkum nazna\u010duje, \u017ee theakrin m\u016f\u017ee zv\u00fd\u0161it uvol\u0148ov\u00e1n\u00ed dopaminu v oblastech mozku, kter\u00e9 se pod\u00edlej\u00ed na motivaci a odm\u011b\u0148ov\u00e1n\u00ed, jako je prefront\u00e1ln\u00ed k\u016fra a striatum. V\u00fdsledkem je zlep\u0161en\u00ed n\u00e1lady, koncentrace a kognitivn\u00edho v\u00fdkonu, podobn\u011b jako u tradi\u010dn\u00edch stimulanci\u00ed, ale bez nadm\u011brn\u00e9 stimulace a rizika z\u00e1vislosti spojen\u00e9ho s l\u00e1tkami, jako je kofein nebo amfetaminy. Teakrin m\u00e1 tak\u00e9 ve srovn\u00e1n\u00ed s kofeinem prodlou\u017een\u00fd \u00fa\u010dinek. Zat\u00edmco \u00fa\u010dinky kofeinu obvykle vrchol\u00ed a odezn\u00edvaj\u00ed b\u011bhem n\u011bkolika hodin, Teakrin poskytuje trval\u00e9 kognitivn\u00ed \u00fa\u010dinky a \u00fa\u010dinky zlep\u0161uj\u00edc\u00ed n\u00e1ladu po del\u0161\u00ed dobu, co\u017e m\u016f\u017ee pomoci udr\u017eet konzistentn\u00ed dopaminovou signalizaci po cel\u00fd den. Tento dlouhodob\u00fd \u00fa\u010dinek je \u010d\u00e1ste\u010dn\u011b zp\u016fsoben \u00fa\u010dinkem theakrinu na citlivost dopaminov\u00fdch receptor\u016f a jeho schopnost\u00ed postupn\u011b zvy\u0161ovat uvol\u0148ov\u00e1n\u00ed dopaminu v pr\u016fb\u011bhu \u010dasu. <a href=\"https:\/\/magistralbr.caldic.com\/storage\/product-files\/624080992.pdf\" target=\"_blank\" rel=\"noopener\"><sup>(35)<\/sup><\/a><\/p>\n<p>Nav\u00edc m\u00e1 theakrin neuroprotektivn\u00ed vlastnosti, kter\u00e9 mohou pomoci chr\u00e1nit neurony produkuj\u00edc\u00ed dopamin p\u0159ed po\u0161kozen\u00edm. To m\u016f\u017ee b\u00fdt prosp\u011b\u0161n\u00e9 pro udr\u017een\u00ed zdrav\u00e9 dopaminergn\u00ed funkce, zejm\u00e9na u lid\u00ed, kte\u0159\u00ed poci\u0165uj\u00ed kognitivn\u00ed \u00fanavu nebo stres. Kombinace zv\u00fd\u0161en\u00e9ho uvol\u0148ov\u00e1n\u00ed dopaminu, dlouhotrvaj\u00edc\u00edch \u00fa\u010dink\u016f a vlastnost\u00ed zlep\u0161uj\u00edc\u00edch n\u00e1ladu \u010din\u00ed z Theacrinu obl\u00edbenou volbu pro ty, kte\u0159\u00ed hledaj\u00ed nootropikum podporuj\u00edc\u00ed kognitivn\u00ed v\u00fdkon i emo\u010dn\u00ed pohodu bez rizika z\u00e1vislosti nebo tolerance spojen\u00e9 s jin\u00fdmi stimulanty. Theacrine tedy nejen zvy\u0161uje uvol\u0148ov\u00e1n\u00ed dopaminu a aktivitu receptor\u016f, co\u017e vede ke zlep\u0161en\u00ed n\u00e1lady, motivace a kognitivn\u00edch funkc\u00ed, ale tak\u00e9 zprost\u0159edkov\u00e1v\u00e1 postupn\u00fd a trval\u00fd \u00fa\u010dinek, co\u017e z n\u011bj \u010din\u00ed \u0161etrn\u011bj\u0161\u00ed alternativu k jin\u00fdm stimulant\u016fm. <a href=\"https:\/\/magistralbr.caldic.com\/storage\/product-files\/624080992.pdf\" target=\"_blank\" rel=\"noopener\"><sup>(35)<\/sup><\/a><\/p>\n<h2>Vliv mucuny na hladinu dopaminu<\/h2>\n<p>Mucuna pruriens, zn\u00e1m\u00e1 tak\u00e9 jako aksamitn\u00edk, je tropick\u00e1 rostlina, kter\u00e1 se v tradi\u010dn\u00ed medic\u00edn\u011b dlouhodob\u011b pou\u017e\u00edv\u00e1 pro sv\u00e9 l\u00e9\u010debn\u00e9 \u00fa\u010dinky, zejm\u00e9na p\u0159i l\u00e9\u010db\u011b Parkinsonovy choroby a sexu\u00e1ln\u00edch dysfunkc\u00ed. Kl\u00ed\u010dovou slo\u017ekou Mucuna pruriens zodpov\u011bdnou za jej\u00ed \u00fa\u010dinek na dopamin je L-DOPA, p\u0159\u00edm\u00fd prekurzor dopaminu. Mucuna pruriens je tedy siln\u00fd p\u0159\u00edrodn\u00ed prekurzor dopaminu, kter\u00fd dok\u00e1\u017ee v\u00fdrazn\u011b zv\u00fd\u0161it hladinu dopaminu v mozku. Mucuna pruriens se \u010dasto pou\u017e\u00edv\u00e1 jako dopln\u011bk stravy, kter\u00fd pom\u00e1h\u00e1 zv\u00fd\u0161it hladinu dopaminu u lid\u00ed s jeho nedostatkem, nap\u0159. u lid\u00ed trp\u00edc\u00edch Parkinsonovou chorobou. L-DOPA z mucuny se p\u016fsoben\u00edm enzymu dopamin-dekarboxyl\u00e1zy p\u0159em\u011b\u0148uje na dopamin. To pom\u00e1h\u00e1 obnovit funkci dopaminu v oblastech mozku, kter\u00e9 se pod\u00edlej\u00ed na \u0159\u00edzen\u00ed motoriky, odm\u011b\u0148ov\u00e1n\u00ed a regulaci n\u00e1lady. Zv\u00fd\u0161en\u00edm dostupnosti L-DOPA m\u016f\u017ee Mucuna pruriens p\u0159isp\u011bt ke zv\u00fd\u0161en\u00ed produkce dopaminu v mozku, co\u017e vede ke zlep\u0161en\u00ed motorick\u00e9 kontroly, zlep\u0161en\u00ed n\u00e1lady a zv\u00fd\u0161en\u00ed motivace. Tento \u00fa\u010dinek je zvl\u00e1\u0161t\u011b d\u016fle\u017eit\u00fd pro lidi trp\u00edc\u00ed onemocn\u011bn\u00edmi, jako je Parkinsonova choroba, p\u0159i nich\u017e neurony produkuj\u00edc\u00ed dopamin v mozku degeneruj\u00ed, co\u017e vede k poruch\u00e1m motoriky a n\u00e1lady. <a href=\"https:\/\/www.rjpponline.org\/HTML_Papers\/Research%20Journal%20of%20Pharmacognosy%20and%20Phytochemistry__PID__2024-16-4-15.html\" target=\"_blank\" rel=\"noopener\"><sup>(36)<\/sup><\/a><\/p>\n<p>Krom\u011b Parkinsonovy choroby mohou b\u00fdt dopaminergn\u00ed \u00fa\u010dinky mucuny u\u017eite\u010dn\u00e9 tak\u00e9 pro osoby trp\u00edc\u00ed depres\u00ed, stresem nebo n\u00edzkou motivac\u00ed, proto\u017ee dopamin hraje kl\u00ed\u010dovou roli v regulaci n\u00e1lady a zpracov\u00e1n\u00ed odm\u011bn. Mucuna m\u016f\u017ee podpo\u0159it n\u00e1ladu a celkovou pohodu dopln\u011bn\u00edm hladiny dopaminu. Krom\u011b zv\u00fd\u0161en\u00ed produkce dopaminu m\u00e1 mucuna i neuroprotektivn\u00ed \u00fa\u010dinky. V\u00fdzkum nazna\u010duje, \u017ee m\u016f\u017ee pom\u00e1hat chr\u00e1nit neurony produkuj\u00edc\u00ed dopamin p\u0159ed oxida\u010dn\u00edm stresem, kter\u00fd m\u016f\u017ee \u010dasem zp\u016fsobit po\u0161kozen\u00ed neuron\u016f. To je zvl\u00e1\u0161t\u011b prosp\u011b\u0161n\u00e9 pro zachov\u00e1n\u00ed funkce dopaminu v mozku, zejm\u00e9na v p\u0159\u00edpadech st\u00e1rnut\u00ed nebo neurodegenerativn\u00edch onemocn\u011bn\u00ed. <a href=\"https:\/\/www.rjpponline.org\/HTML_Papers\/Research%20Journal%20of%20Pharmacognosy%20and%20Phytochemistry__PID__2024-16-4-15.html\" target=\"_blank\" rel=\"noopener\"><sup>(36)<\/sup><\/a><\/p>\n<p>Mucuna pruriens celkov\u011b zvy\u0161uje hladinu dopaminu t\u00edm, \u017ee poskytuje p\u0159\u00edrodn\u00ed zdroj L-DOPA, kter\u00fd se v mozku p\u0159em\u011b\u0148uje na dopamin. Podporuje n\u00e1ladu, kognitivn\u00ed a motorick\u00e9 funkce a d\u00edky sv\u00fdm neuroprotektivn\u00edm vlastnostem je cenn\u00fdm dopl\u0148kem pro udr\u017een\u00ed zdrav\u00e9 dopaminergn\u00ed aktivity. <a href=\"https:\/\/www.rjpponline.org\/HTML_Papers\/Research%20Journal%20of%20Pharmacognosy%20and%20Phytochemistry__PID__2024-16-4-15.html\" target=\"_blank\" rel=\"noopener\"><sup>(36)<\/sup><\/a><\/p>\n<h2>Testov\u00e1n\u00ed hladiny dopaminu - stimulace dopaminergn\u00edch \u00fa\u010dink\u016f na vlastn\u00ed k\u016f\u017ei!<\/h2>\n<p>Dopamin je chemick\u00e1 l\u00e1tka, kter\u00e1 je v mozku zodpov\u011bdn\u00e1 za \"dobr\u00e9 pocity\" a souvis\u00ed s motivac\u00ed, odm\u011bnou a pot\u011b\u0161en\u00edm. Zv\u00fd\u0161en\u00ed hladiny dopaminu p\u0159irozenou cestou prost\u0159ednictv\u00edm ka\u017edodenn\u00edch aktivit m\u016f\u017ee zlep\u0161it n\u00e1ladu, koncentraci a motivaci. Zde je n\u011bkolik jednoduch\u00fdch zp\u016fsob\u016f, jak stimulovat dopamin v b\u011b\u017en\u00e9m \u017eivot\u011b <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC11223451\/\" target=\"_blank\" rel=\"noopener\"><sup>(37)) <\/sup><\/a><a href=\"https:\/\/philpapers.org\/rec\/MALTBN\" target=\"_blank\" rel=\"noopener\"><sup>((38)<\/sup><\/a>:<\/p>\n<h4>Stanovte si mal\u00e9 c\u00edle:<\/h4>\n<p>Spln\u011bn\u00ed drobn\u00fdch \u00fakol\u016f, jako je od\u0161krt\u00e1v\u00e1n\u00ed dal\u0161\u00edch polo\u017eek na seznamu \u00fakol\u016f, vyvol\u00e1v\u00e1 uvol\u0148ov\u00e1n\u00ed dopaminu. Ka\u017ed\u00fd mal\u00fd \u00fasp\u011bch v\u00e1m dod\u00e1 pocit uspokojen\u00ed, kter\u00fd v\u00e1s motivuje k dal\u0161\u00ed pr\u00e1ci.<\/p>\n<h4>Pravideln\u011b cvi\u010dte:<\/h4>\n<p>Fyzick\u00e1 aktivita, a\u0165 u\u017e se jedn\u00e1 o ch\u016fzi, j\u00f3gu nebo tr\u00e9nink, zvy\u0161uje hladinu dopaminu t\u00edm, \u017ee stimuluje jeho uvol\u0148ov\u00e1n\u00ed. Cvi\u010den\u00ed nejen\u017ee zvy\u0161uje hladinu dopaminu, ale uvol\u0148uje tak\u00e9 dal\u0161\u00ed chemick\u00e9 l\u00e1tky zlep\u0161uj\u00edc\u00ed n\u00e1ladu, jako je serotonin a endorfiny.<\/p>\n<h4>Jezte potraviny, kter\u00e9 zvy\u0161uj\u00ed hladinu dopaminu:<\/h4>\n<p>Potraviny bohat\u00e9 na tyrosin (nap\u0159. hov\u011bz\u00ed maso, vejce a fazole) jsou pro tvorbu dopaminu nezbytn\u00e9. Ke zv\u00fd\u0161en\u00ed hladiny dopaminu p\u0159isp\u00edv\u00e1 tak\u00e9 ovoce, jako jsou ban\u00e1ny a \u010derven\u00e1 \u0159epa, a dokonce i ho\u0159k\u00e1 \u010dokol\u00e1da.<\/p>\n<h4>Dob\u0159e se vysp\u011bte:<\/h4>\n<p>Nedostatek sp\u00e1nku m\u016f\u017ee sn\u00ed\u017eit citlivost dopaminov\u00fdch receptor\u016f, co\u017e zt\u011b\u017euje pocit motivace. Pro udr\u017een\u00ed optim\u00e1ln\u00ed funkce dopaminu se sna\u017ete sp\u00e1t 7-9 hodin.<\/p>\n<h4>Poslouchejte hudbu:<\/h4>\n<p>Va\u0161e obl\u00edben\u00e9 p\u00edsn\u011b mohou zv\u00fd\u0161it hladinu dopaminu, zejm\u00e9na pokud v\u00e1m zvednou n\u00e1ladu nebo v\u00e1s emocion\u00e1ln\u011b zaujmou. Hudba aktivuje mozkov\u00fd syst\u00e9m odm\u011bn a dod\u00e1 v\u00e1m rychlou d\u00e1vku dopaminu.<\/p>\n<h4>Soci\u00e1ln\u00ed interakce:<\/h4>\n<p>Pozitivn\u00ed soci\u00e1ln\u00ed interakce, a\u0165 u\u017e s rodinou, p\u0159\u00e1teli nebo kolegy, vyvol\u00e1vaj\u00ed uvol\u0148ov\u00e1n\u00ed dopaminu. I projevy laskavosti nebo uzn\u00e1n\u00ed mohou zlep\u0161it n\u00e1ladu.<\/p>\n<h4>U\u010den\u00ed se nov\u00fdm v\u011bcem:<\/h4>\n<p>Novinka stimuluje dopamin. Vyzkou\u0161en\u00ed nov\u00fdch aktivit, nau\u010den\u00ed se n\u011b\u010deho nov\u00e9ho nebo zm\u011bna rutiny m\u016f\u017ee zv\u00fd\u0161it hladinu dopaminu a poskytnout uspokojuj\u00edc\u00ed z\u00e1\u017eitek. Za\u0159azen\u00ed t\u011bchto \u010dinnost\u00ed do ka\u017edodenn\u00ed rutiny m\u016f\u017ee z\u00e1m\u011brn\u011b zv\u00fd\u0161it produkci dopaminu, co\u017e vede ke zlep\u0161en\u00ed n\u00e1lady a motivace.<\/p>\n<h2>Mozkov\u00e9 biohacky pro zv\u00fd\u0161en\u00ed hladiny dopaminu - z pohledu neurov\u011bdce<\/h2>\n<p>Zde je n\u011bkolik tip\u016f pro mozek, kter\u00e9 mohou pomoci stimulovat produkci dopaminu, zlep\u0161it n\u00e1ladu, koncentraci a motivaci. Tyto jednoduch\u00e9 \u010dinnosti lze snadno za\u010dlenit do ka\u017edodenn\u00edho \u017eivota:<\/p>\n<h3>Konzumace obl\u00edben\u00fdch j\u00eddel (nebo sladkost\u00ed)<\/h3>\n<p>Konzumace n\u011b\u010deho, co m\u00e1te r\u00e1di, nap\u0159\u00edklad obl\u00edben\u00e9ho dezertu nebo sva\u010diny, m\u016f\u017ee vyvolat uvol\u0148ov\u00e1n\u00ed dopaminu. Pot\u011b\u0161en\u00ed z konzumace n\u011b\u010deho chutn\u00e9ho je p\u0159irozen\u00fdm posilova\u010dem. Kl\u00ed\u010dem k \u00fasp\u011bchu je v\u0161ak um\u00edrn\u011bnost, proto\u017ee nadm\u011brn\u00e9 po\u017eitk\u00e1\u0159stv\u00ed m\u016f\u017ee v\u00e9st k pozd\u011bj\u0161\u00edmu \"p\u00e1du\". \u010casto tento zp\u016fsob nadu\u017e\u00edv\u00e1me, pokud nedb\u00e1me na dal\u0161\u00ed dopaminov\u00e9 spou\u0161t\u011b\u010de, co\u017e m\u016f\u017ee v\u00e9st k obezit\u011b. <a href=\"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2018.00271\/full\" target=\"_blank\" rel=\"noopener\"><sup>(39)<\/sup><\/a><\/p>\n<h3>Od\u010derp\u00e1v\u00e1n\u00ed dopaminu ze soci\u00e1ln\u00edch m\u00e9di\u00ed<\/h3>\n<p>Proch\u00e1zen\u00ed soci\u00e1ln\u00edch m\u00e9di\u00ed m\u016f\u017ee v\u00e9st k n\u00e1r\u016fstu dopaminu, ale \u010dasto vede sp\u00ed\u0161e k jeho \"odlivu\" ne\u017e ke skute\u010dn\u00e9mu zv\u00fd\u0161en\u00ed. Neust\u00e1l\u00e1 ozn\u00e1men\u00ed a \"lajky\" vyvol\u00e1vaj\u00ed mal\u00e9 uvoln\u011bn\u00ed dopaminu, ale \u010dasem to m\u016f\u017ee v\u00e9st k m\u00e9n\u011b v\u00fdznamn\u00e9mu uspokojen\u00ed. Omezte pou\u017e\u00edv\u00e1n\u00ed soci\u00e1ln\u00edch m\u00e9di\u00ed, abyste se vyhnuli pocitu vy\u010derp\u00e1n\u00ed a zv\u00fd\u0161ili kvalitu online interakc\u00ed. <a href=\"https:\/\/www.malone.edu\/files\/resources\/revised-final-thesis-2020.pdf\" target=\"_blank\" rel=\"noopener\"><sup>(40)<\/sup><\/a><\/p>\n<h3>Studen\u00e9 sprchy<\/h3>\n<p>Studen\u00e1 sprcha nebo koupel ve studen\u00e9 vod\u011b je rychl\u00fd zp\u016fsob, jak zv\u00fd\u0161it hladinu dopaminu. Studen\u00e1 voda zvy\u0161uje bd\u011blost, sni\u017euje stres a prokazateln\u011b zlep\u0161uje n\u00e1ladu t\u00edm, \u017ee zvy\u0161uje hustotu dopaminov\u00fdch receptor\u016f. Pocit zadostiu\u010din\u011bn\u00ed po studen\u00e9 spr\u0161e m\u016f\u017ee tak\u00e9 poskytnout dopaminovou odm\u011bnu. <a href=\"https:\/\/cyberleninka.ru\/article\/n\/dopamine-friend-or-foe\" target=\"_blank\" rel=\"noopener\"><sup>(41)<\/sup><\/a><\/p>\n<h3>Vystaven\u00ed slune\u010dn\u00edmu z\u00e1\u0159en\u00ed<\/h3>\n<p>P\u0159irozen\u00e9 slune\u010dn\u00ed sv\u011btlo pom\u00e1h\u00e1 zvy\u0161ovat hladinu dopaminu. Slune\u010dn\u00ed sv\u011btlo spou\u0161t\u00ed produkci serotoninu a dopaminu, co\u017e pom\u00e1h\u00e1 zlep\u0161ovat n\u00e1ladu a hladinu energie. Sna\u017ete se ka\u017ed\u00fd den alespo\u0148 15 minut sv\u00edtit na slunci, zejm\u00e9na r\u00e1no, abyste p\u0159irozen\u011b zv\u00fd\u0161ili hladinu dopaminu. <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0278584610003659?casa_token=HHGtLe3xkVoAAAAA:aQCGpVInSd0B4jp2R4SdyYD1rQYsAyxrxmXyvCkxjbZJOLhCvh_nbS_MOicrJQqhDHB6ZoNezlw\" target=\"_blank\" rel=\"noopener\"><sup>(42)<\/sup><\/a><\/p>\n<h2>Odm\u00edtnut\u00ed odpov\u011bdnosti<\/h2>\n<p>Tento \u010dl\u00e1nek byl naps\u00e1n pro vzd\u011bl\u00e1vac\u00ed \u00fa\u010dely a jeho c\u00edlem je zv\u00fd\u0161it pov\u011bdom\u00ed o diskutovan\u00e9 l\u00e1tce. Je d\u016fle\u017eit\u00e9 si uv\u011bdomit, \u017ee \u010dl\u00e1nek pojedn\u00e1v\u00e1 o l\u00e1tce obecn\u011b - nejedn\u00e1 se o popis konkr\u00e9tn\u00edho v\u00fdrobku (chemick\u00e9ho \u010dinidla). Nenavrhujeme pou\u017eit\u00ed chemick\u00fdch \u010dinidel na lidech - to je z\u00e1konem zak\u00e1z\u00e1no, aby mohl b\u00fdt v\u00fdrobek pou\u017eit k l\u00e9\u010db\u011b, mus\u00ed b\u00fdt registrov\u00e1n jako l\u00e9k. Informace obsa\u017een\u00e9 v textu jsou zalo\u017eeny na dostupn\u00fdch v\u011bdeck\u00fdch v\u00fdzkumech a nejsou ur\u010deny jako l\u00e9ka\u0159sk\u00e9 doporu\u010den\u00ed nebo propagace samol\u00e9\u010dby. \u010cten\u00e1\u0159 by m\u011bl ve\u0161ker\u00e1 rozhodnut\u00ed t\u00fdkaj\u00edc\u00ed se zdrav\u00ed a l\u00e9\u010dby konzultovat s kvalifikovan\u00fdm zdravotnick\u00fdm pracovn\u00edkem.<\/p>\n<p>&nbsp;<\/p>\n<h2>Odkazy:<\/h2>\n<ol>\n<li>Berke, J. D. (2018). Co znamen\u00e1 dopamin? <em>P\u0159\u00edrodn\u00ed neurov\u011bdy<\/em>, <em>21<\/em>(6), 787-793.<\/li>\n<li>Misu, Y., &amp; Goshima, Y. (Eds.). (2005). <em>Neurobiologie DOPA jako neurotransmiteru<\/em>. CRC Press.<\/li>\n<li>Ben-Jonathan, N. (1985). Dopamin: hormon inhibuj\u00edc\u00ed prolaktin. <em>Endokrinn\u00ed recenze<\/em>, <em>6<\/em>(4), 564-589.<\/li>\n<li>Dreyer, D. R., Miller, D. J., Freeman, B. D., Paul, D. R., &amp; Bielawski, C. W. (2012). Objasn\u011bn\u00ed struktury poly(dopaminu). <em>Langmuir<\/em>, <em>28<\/em>(15), 6428-6435.<\/li>\n<li>Krzymowski, T., &amp; Stefa\u0144czyk-Krzymowska, S. (2015). Nov\u00e1 fakta a pojet\u00ed fyziologick\u00e9 regulace funkce dopaminergn\u00edho syst\u00e9mu a jeho poruch. <em>J Physiol Pharmacol<\/em>, <em>66<\/em>(3), 331-341.<\/li>\n<li>Neumann, J., Hofmann, B., Dhein, S., &amp; Gergs, U. (2023). \u00daloha srde\u010dn\u00edho dopaminu ve zdrav\u00ed a nemoci. <em>International Journal of Molecular Sciences<\/em>, <em>24<\/em>(5), 5042.<\/li>\n<li>Dive, A., Foret, F., Jamart, J., Bulpa, P., &amp; Install\u00e9, E. (2000). \u00da\u010dinky dopaminu na gastrointestin\u00e1ln\u00ed motilitu b\u011bhem kritick\u00e9ho onemocn\u011bn\u00ed. <em>Intenzivn\u00ed medic\u00edna<\/em>, <em>26<\/em>, 901-907.<\/li>\n<li>Liu, C., &amp; Kaeser, P. S. (2019). Mechanismy a regulace uvol\u0148ov\u00e1n\u00ed dopaminu. <em>Aktu\u00e1ln\u00ed n\u00e1zory v neurov\u011bd\u00e1ch<\/em>, <em>57<\/em>, 46-53.<\/li>\n<li>Beaulieu, J. M., Espinoza, S., &amp; Gainetdinov, R. R. (2015). Dopaminov\u00e9 receptory-IUPHAR R eview 13. <em>British journal of pharmacology<\/em>, <em>172<\/em>(1), 1-23.<\/li>\n<li>Janhunen, S., &amp; Ahtee, L. (2007). Diferenci\u00e1ln\u00ed nikotinov\u00e1 regulace nigrostriat\u00e1ln\u00edch a mezolimbick\u00fdch dopaminergn\u00edch drah: d\u016fsledky pro v\u00fdvoj l\u00e9k\u016f. <em>Neurov\u011bdy a biobehavior\u00e1ln\u00ed recenze<\/em>, <em>31<\/em>(3), 287-314.<\/li>\n<li>Yokochi, M. (2007). Mezolimbick\u00e9 a mezokortik\u00e1ln\u00ed dr\u00e1hy u Parkinsonovy nemoci. <em>Mozek a nervy= Shinkei kenkyu no shinpo<\/em>, <em>59<\/em>(9), 943-951.<\/li>\n<li>Amenta, F., Ricci, A., Tayebati, S. K., &amp; Zaccheo, D. (2002). Perifern\u00ed dopaminergn\u00ed syst\u00e9m: morfologick\u00e1 anal\u00fdza, funk\u010dn\u00ed a klinick\u00e9 aplikace. <em>Italsk\u00fd \u010dasopis pro anatomii a embryologii<\/em>, <em>107<\/em>(3), 145-167.<\/li>\n<li>Hashemi, P., Dankoski, E. C., Lama, R., Wood, K. M., Takmakov, P., &amp; Wightman, R. M. (2012). Dopamin a serotonin v mozku se li\u0161\u00ed v regulaci a d\u016fsledc\u00edch. <em>Sborn\u00edk N\u00e1rodn\u00ed akademie v\u011bd<\/em>, <em>109<\/em>(29), 11510-11515.<\/li>\n<li>Lambert, G., Johansson, M., \u00c5gren, H., &amp; Friberg, P. (2000). Sn\u00ed\u017een\u00e9 mozkov\u00e9 uvol\u0148ov\u00e1n\u00ed noradrenalinu a dopaminu u depresivn\u00edch onemocn\u011bn\u00ed rezistentn\u00edch na l\u00e9\u010dbu: d\u016fkaz na podporu katecholaminov\u00e9 hypot\u00e9zy poruch n\u00e1lady. <em>Archives of general psychiatry<\/em>, <em>57<\/em>(8), 787-793.<\/li>\n<li>Qi, Z., Kikuchi, S., Tretter, F., &amp; Voit, E. O. (2011). \u00da\u010dinky dopaminu a glutam\u00e1tu na synaptickou plasticitu: p\u0159\u00edstup k po\u010d\u00edta\u010dov\u00e9mu modelov\u00e1n\u00ed zneu\u017e\u00edv\u00e1n\u00ed drog jako komorbidity u poruch n\u00e1lady. <em>Farmakopsychiatrie<\/em>, <em>44<\/em>(S 01), S62-S75.<\/li>\n<li>Narvaes, R., &amp; Martins de Almeida, R. M. (2014). Agresivn\u00ed chov\u00e1n\u00ed a t\u0159i neurotransmitery: dopamin, GABA a serotonin - p\u0159ehled za posledn\u00edch 10 let. <em>Psychologie a neurov\u011bdy<\/em>, <em>7<\/em>(4), 601.<\/li>\n<li>Boesgaard, S., Hagen, C., Andersen, A. N., Fenger, M., &amp; Eldrup, E. (1990). Vliv modulace dopaminu, dopaminov\u00fdch receptor\u016f D-1 a D-2 na hladiny ACTH a kortizolu u norm\u00e1ln\u00edch mu\u017e\u016f a \u017een. <em>European Journal of Endocrinology<\/em>, <em>122<\/em>(1), 29-36.<\/li>\n<li>Petersson, M., &amp; Uvn\u00e4s-Moberg, K. (2024). Interakce oxytocinu a dopaminu - vliv na chov\u00e1n\u00ed ve zdrav\u00ed a nemoci. <em>Biomedic\u00edna<\/em>, <em>12<\/em>(11), 2440.<\/li>\n<li>Zheng, R. (2022). Pleasure and achievement (Pot\u011b\u0161en\u00ed a \u00fasp\u011bch): Dopamin a endorfiny. <em>Nejd\u016fle\u017eit\u011bj\u0161\u00ed ud\u00e1losti v oblasti v\u011bdy, techniky a technologie<\/em>, <em>6<\/em>, 83-89.<\/li>\n<li>Imperato, A., Puglisi-Allegra, S., Casolini, P., &amp; Angelucci, L. (1991). Zm\u011bny v uvol\u0148ov\u00e1n\u00ed dopaminu a acetylcholinu v mozku b\u011bhem stresu a po n\u011bm jsou nez\u00e1visl\u00e9 na ose hypof\u00fdza-k\u016fra nadledvin. <em>V\u00fdzkum mozku<\/em>, <em>538<\/em>(1), 111-117.<\/li>\n<li>Bressan, R. A., &amp; Crippa, J. A. (2005). \u00daloha dopaminu v odm\u011b\u0148ov\u00e1n\u00ed a chov\u00e1n\u00ed souvisej\u00edc\u00edm s pot\u011b\u0161en\u00edm - p\u0159ehled \u00fadaj\u016f z preklinick\u00fdch studi\u00ed. <em>Acta Psychiatrica Scandinavica<\/em>, <em>111<\/em>, 14-21.<\/li>\n<li>Leyton, M. (2010). Neurobiologie touhy: Dopamin a regulace n\u00e1lady a motiva\u010dn\u00edch stav\u016f u lid\u00ed.<\/li>\n<li>Heller, R. (2011). Zpomalen\u00ed spot\u0159ebitelsk\u00e9ho b\u011bhu na b\u011b\u017e\u00edc\u00edm p\u00e1su. <em>Humanista<\/em>, <em>71<\/em>(4), 30.<\/li>\n<li>Oishi, Y., &amp; Lazarus, M. (2017). \u0158\u00edzen\u00ed sp\u00e1nku a bd\u011bn\u00ed mezolimbick\u00fdmi dopaminov\u00fdmi syst\u00e9my. <em>Neurov\u011bdeck\u00fd v\u00fdzkum<\/em>, <em>118<\/em>, 66-73.<\/li>\n<li>Berridge, K. C., &amp; Robinson, T. E. (1998). Jak\u00e1 je role dopaminu v odm\u011b\u0148ov\u00e1n\u00ed: hedonick\u00fd vliv, u\u010den\u00ed se odm\u011bn\u011b nebo relevance podn\u011btu? <em>Recenze v\u00fdzkumu mozku<\/em>, <em>28<\/em>(3), 309-369.<\/li>\n<li>Docherty, J. R., &amp; Alsufyani, H. A. (2021). Farmakologie drog pou\u017e\u00edvan\u00fdch jako stimulancia. <em>Journal of Clinical Pharmacology<\/em>, <em>61<\/em>, S53-S69.<\/li>\n<li>Sinclair, D., Purves-Tyson, T. D., Allen, K. M., &amp; Weickert, C. S. (2014). Vliv stresu a pohlavn\u00edch hormon\u016f na dopaminovou neurotransmisi v mozku dosp\u00edvaj\u00edc\u00edch. <em>Psychofarmakologie<\/em>, <em>231<\/em>, 1581-1599.<\/li>\n<li>Martin-Iverson, M. T., &amp; Yamada, N. (1992). Synergick\u00e9 behavior\u00e1ln\u00ed \u00fa\u010dinky agonist\u016f dopaminov\u00fdch receptor\u016f D1 a D2 jsou ur\u010deny cirkadi\u00e1nn\u00edmi rytmy. <em>European journal of pharmacology<\/em>, <em>215<\/em>(1), 119-125.<\/li>\n<li>Young, A. M., Moran, P. M., &amp; Joseph, M. H. (2005). \u00daloha dopaminu v podmi\u0148ov\u00e1n\u00ed a latentn\u00ed inhibici: co, kdy, kde a jak? <em>Neurov\u011bdy a biobehavior\u00e1ln\u00ed recenze<\/em>, <em>29<\/em>(6), 963-976.<\/li>\n<li>Ashok, A. H., Mizuno, Y., Volkow, N. D., &amp; Howes, O. D. (2017). Asociace u\u017e\u00edv\u00e1n\u00ed stimulanci\u00ed s dopaminergn\u00edmi zm\u011bnami u u\u017eivatel\u016f kokainu, amfetaminu nebo metamfetaminu: systematick\u00fd p\u0159ehled a metaanal\u00fdza. <em>JAMA psychiatry<\/em>, <em>74<\/em>(5), 511-519.<\/li>\n<li>D. B. F. Dopamin Brain Food by Natural Stacks: p\u0159\u00edrodn\u00ed kognitivn\u00ed vylep\u0161en\u00ed.<\/li>\n<li>Vasileva, L. V., Saracheva, K. \u00c5., Ivanovska, M. V., Petrova, A. P., Sucouglu, E., Murdjeva, M. A., &amp; Getova-Spasova, D. P. (2017). P\u0159\u00edzniv\u00fd \u00fa\u010dinek chronick\u00e9 l\u00e9\u010dby extrakty Rhodiola Rosea L. a Curcuma Longa L. na imunoreaktivitu zv\u00ed\u0159at vystaven\u00fdch modelu chronick\u00e9ho m\u00edrn\u00e9ho stresu. <em>Folia Medica<\/em>, <em>59<\/em>(4), 443-453.<\/li>\n<li>Tardner, P. (2024). Bromantan: pro\u010d v\u0161ichni mluv\u00ed o tomto kognitivn\u00edm zesilova\u010di?<\/li>\n<li>Shirane, M., &amp; Nakamura, K. (2001). Aniracetam zvy\u0161uje uvol\u0148ov\u00e1n\u00ed kortik\u00e1ln\u00edho dopaminu a serotoninu prost\u0159ednictv\u00edm cholinergn\u00edch a glutaminergn\u00edch mechanism\u016f u SHRSP. <em>V\u00fdzkum mozku<\/em>, <em>916<\/em>(1-2), 211-221.<\/li>\n<li>Kuhman, D. J. Kognitivn\u00ed v\u00fdkon a n\u00e1lada po po\u017eit\u00ed dopl\u0148ku stravy obsahuj\u00edc\u00edho teakrin, kofein nebo placebo...<\/li>\n<li>Bhoite, V., &amp; Wagh, S. (2024). Zlep\u0161ete si n\u00e1ladu pomoc\u00ed Mucuna pruriens. <em>V\u00fdzkumn\u00fd \u010dasopis pro farmakognozii a fytochemii<\/em>, <em>16<\/em>(4), 278-281.<\/li>\n<li>Desai, D., Patel, J., Saiyed, F., Upadhyay, H., Kariya, P., &amp; Patel, J. (2024). Literature review on holistic well-being and dopamine fasting: an integrated approach [P\u0159ehled literatury o holistick\u00e9 pohod\u011b a dopaminov\u00e9m p\u016fstu: integrovan\u00fd p\u0159\u00edstup]. <em>Cureus<\/em>, <em>16<\/em>(6).<\/li>\n<li>Malicse, A. Nejlep\u0161\u00ed p\u0159\u00edrodn\u00ed podn\u011bty pro p\u0159\u00edznivou chemii mozku.<\/li>\n<li>Coccurello, R., &amp; Maccarrone, M. (2018). Hedonistick\u00e9 stravov\u00e1n\u00ed a \"lahodn\u00fd kruh\": od medi\u00e1tor\u016f odvozen\u00fdch od lipid\u016f k dopaminu v mozku a zp\u011bt. <em>Hranice neurov\u011bd<\/em>, <em>12<\/em>, 271<\/li>\n<li>Brown, O. (2020). Soci\u00e1ln\u00ed, emocion\u00e1ln\u00ed a neurologick\u00e9 \u00fa\u010dinky p\u0159eru\u0161ovan\u00e9ho odpojen\u00ed od pou\u017e\u00edv\u00e1n\u00ed soci\u00e1ln\u00edch m\u00e9di\u00ed. <em>Nepublikovan\u00e1 magistersk\u00e1 pr\u00e1ce]. Malone University. https:\/\/www. malone. edu\/files\/resources\/revised-final-thesis-2020. pdf.<\/em>.<\/li>\n<li>Yong, K. A. C. (2024). DOPAMIN: P\u0158\u00cdTEL NEBO NEP\u0158\u00cdTEL. <em>Sou\u010dasn\u00e9 inovace<\/em>, (2 (45)), 9-10.<\/li>\n<li>Tsai, H. Y., Chen, K. C., Yang, Y. K., Chen, P. S., Yeh, T. L., Chiu, N. T., &amp; Lee, I. H. (2011). Variace dostupnosti lidsk\u00e9ho striat\u00e1ln\u00edho dopaminov\u00e9ho D2\/D3 receptoru v z\u00e1vislosti na slune\u010dn\u00edm svitu u zdrav\u00fdch dobrovoln\u00edk\u016f. <em>Pokroky v neuro-psychofarmakologii a biologick\u00e9 psychiatrii<\/em>, <em>35<\/em>(1), 107-110.<\/li>\n<\/ol>","protected":false},"excerpt":{"rendered":"<p>Obsah Co je to dopamin?. 1 Dopamin jako neurotransmiter a hormon. 1 Chemick\u00e1 povaha dopaminu. 2 Fyziologick\u00e9 a biologick\u00e9 vlastnosti. 2 Mechanismus \u00fa\u010dinku. 2 Dopaminov\u00e9 receptory.\u2026<\/p>","protected":false},"author":7908,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"footnotes":""},"categories":[],"tags":[],"class_list":["post-29595","post","type-post","status-publish","format-standard","hentry","beh-no-thumb"],"_links":{"self":[{"href":"https:\/\/bioevidencehub.com\/cs\/wp-json\/wp\/v2\/posts\/29595","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bioevidencehub.com\/cs\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bioevidencehub.com\/cs\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bioevidencehub.com\/cs\/wp-json\/wp\/v2\/users\/7908"}],"replies":[{"embeddable":true,"href":"https:\/\/bioevidencehub.com\/cs\/wp-json\/wp\/v2\/comments?post=29595"}],"version-history":[{"count":0,"href":"https:\/\/bioevidencehub.com\/cs\/wp-json\/wp\/v2\/posts\/29595\/revisions"}],"wp:attachment":[{"href":"https:\/\/bioevidencehub.com\/cs\/wp-json\/wp\/v2\/media?parent=29595"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bioevidencehub.com\/cs\/wp-json\/wp\/v2\/categories?post=29595"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bioevidencehub.com\/cs\/wp-json\/wp\/v2\/tags?post=29595"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}